Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
glycolytic process (GO:0006096),29-Jul,1.13E-08,1.92E-05,0,0,32.77769886,599.8927544,LDHA;PFKL;TPI1;PKM;PGK1;ENO1;ALDOA
actin filament organization (GO:0007015),12/152,4.07E-08,3.47E-05,0,0,9.011917494,153.3564775,CDC42;ACTA1;MARCKS;TPM4;ABI2;PLA2G1B;TPM2;TPM1;RHOBTB3;DSTN;FLNA;ALDOA
canonical glycolysis (GO:0061621),24-Jun,1.04E-07,4.16E-05,0,0,34.16753022,549.2738439,PFKL;TPI1;PKM;PGK1;ENO1;ALDOA
glucose catabolic process to pyruvate (GO:0061718),24-Jun,1.04E-07,4.16E-05,0,0,34.16753022,549.2738439,PFKL;TPI1;PKM;PGK1;ENO1;ALDOA
glycolytic process through glucose-6-phosphate (GO:0061620),25-Jun,1.36E-07,4.16E-05,0,0,32.36760295,511.7236741,PFKL;TPI1;PKM;PGK1;ENO1;ALDOA
carbohydrate catabolic process (GO:0016052),7/41,1.47E-07,4.16E-05,0,0,21.19623162,333.5288509,LDHA;PFKL;TPI1;PKM;PGK1;ENO1;ALDOA
muscle contraction (GO:0006936),10/129,6.68E-07,1.63E-04,0,0,8.751055978,124.4304263,ACTA2;ACTA1;TPM4;CALD1;TPM2;TPM1;CALM1;ALDOA;CRYAB;MYL12A
pyruvate metabolic process (GO:0006090),7/55,1.18E-06,2.51E-04,0,0,15.00336372,204.8380295,LDHA;PFKL;TPI1;PKM;PGK1;ENO1;ALDOA
substantia nigra development (GO:0021762),6/43,4.04E-06,7.64E-04,0,0,16.60607758,206.2466694,CDC42;GLUD1;HSPA5;CALM1;INA;ACTB
regulation of substrate adhesion-dependent cell spreading (GO:1900024),6/51,1.12E-05,0.001902285,0,0,13.64835924,155.6301657,CDC42;PDPN;SPRY4;FLNA;ACTN4;S100A10
regulated exocytosis (GO:0045055),10/180,1.34E-05,0.002071594,0,0,6.109866169,68.56660077,RAB31;TMSB4X;MYH9;FLNA;ACTN4;CALM1;ALDOA;CLU;STEAP2;THBS1
regulation of cell migration (GO:0030334),14/408,6.22E-05,0.008836215,0,0,3.727507203,36.09987732,BEX4;HSPA5;TPM1;SEMA3E;LAMB1;ACTN4;F3;THBS1;AFDN;TMSB4X;PDPN;FLNA;AMOTL2;ARID2
negative regulation of apoptotic process (GO:0043066),15/485,1.09E-04,0.014281203,0,0,3.352971785,30.59451112,BEX3;HSPA5;BNIP3;PLAUR;BRAF;LRP2;FSTL1;YWHAZ;THBS1;HSP90B1;KRT18;PDPN;FLNA;SFN;CRYAB
negative regulation of programmed cell death (GO:0043069),13/381,1.21E-04,0.014688807,0,0,3.690816386,33.29982205,HSPA5;BNIP3;PLAUR;BRAF;LRP2;FSTL1;YWHAZ;THBS1;HSP90B1;KRT18;PDPN;FLNA;CRYAB
negative regulation of protein-containing complex assembly (GO:0031333),5/52,1.65E-04,0.018730442,0,0,10.83241939,94.35349976,CDC42;IMPACT;HSPA5;CLU;CRYAB
platelet degranulation (GO:0002576),7/125,2.57E-04,0.027413896,0,0,6.081435381,50.26215253,TMSB4X;FLNA;ACTN4;CALM1;ALDOA;CLU;THBS1
phosphate-containing compound metabolic process (GO:0006796),9/212,2.82E-04,0.028284863,0,0,4.573036038,37.37518961,PFKL;PPA1;GPD2;GFPT2;PGK1;ENPP3;NUDT5;CALM1;ALDOA
platelet aggregation (GO:0070527),4/36,4.37E-04,0.041235734,0,0,12.6724359,98.04154755,FLNA;MYH9;ACTB;MYL12A
regulation of apoptotic process (GO:0042981),18/742,4.62E-04,0.041235734,0,0,2.620387046,20.12714601,HSPA5;BNIP3;PLAUR;BRAF;ACTN4;LRP2;FSTL1;CLU;YWHAZ;THBS1;DUSP6;HSP90B1;LGALS1;KRT18;PERP;PDPN;FLNA;CRYAB
positive regulation of macromolecule metabolic process (GO:0010604),12/384,4.87E-04,0.041235734,0,0,3.351561152,25.5656199,ACTA2;AFDN;ACTA1;GJA1;INPP5F;ANXA2;ID2;DNMT3B;BRAF;F3;CLU;SLC38A2
actin-myosin filament sliding (GO:0033275),4/38,5.39E-04,0.041235734,0,0,11.92579186,89.75916282,ACTA1;TPM4;TPM2;TPM1
muscle filament sliding (GO:0030049),4/38,5.39E-04,0.041235734,0,0,11.92579186,89.75916282,ACTA1;TPM4;TPM2;TPM1
cellular response to organonitrogen compound (GO:0071417),6/103,5.78E-04,0.041235734,0,0,6.315047273,47.0855767,IMPACT;LARP1;CAPN2;ACTB;IPO5;HSP90B1
nitrogen compound transport (GO:0071705),7/143,5.81E-04,0.041235734,0,0,5.271714154,39.28022714,SLC7A7;PDPN;TXNIP;MYH9;LRP2;SLC38A2;HSP90B1
negative regulation of cell-substrate adhesion (GO:0010812),4/40,6.57E-04,0.044755357,0,0,11.26210826,82.53325696,SPRY4;SEMA3E;ACTN4;THBS1
gluconeogenesis (GO:0006094),4/41,7.22E-04,0.047318301,0,0,10.95717256,79.2586564,TPI1;PGK1;ENO1;ALDOA
cell junction organization (GO:0034330),5/72,7.56E-04,0.047481908,0,0,7.591167872,54.56102849,CDC42;PPFIBP1;FLNA;SEMA3E;ACTB
regulation of glucose transmembrane transport (GO:0010827),19-Mar,8.36E-04,0.047481908,0,0,18.92697704,134.1344045,PLA2G1B;SLC2A1;BRAF
DNA alkylation (GO:0006305),19-Mar,8.36E-04,0.047481908,0,0,18.92697704,134.1344045,DNMT3L;DNMT3A;DNMT3B
DNA methylation or demethylation (GO:0044728),19-Mar,8.36E-04,0.047481908,0,0,18.92697704,134.1344045,DNMT3L;DNMT3A;DNMT3B
hexose biosynthetic process (GO:0019319),4/44,9.46E-04,0.048455043,0,0,10.13384615,70.56897453,TPI1;PGK1;ENO1;ALDOA
homotypic cell-cell adhesion (GO:0034109),4/44,9.46E-04,0.048455043,0,0,10.13384615,70.56897453,FLNA;MYH9;ACTB;MYL12A
glucose import across plasma membrane (GO:0098708),05-Feb,9.66E-04,0.048455043,0,0,66.99830795,465.1386275,SLC2A1;SLC2A3
actomyosin structure organization (GO:0031032),5/76,9.67E-04,0.048455043,0,0,7.162044432,49.71527445,KRT19;TPM1;ZYX;MYH9;MYH10
positive regulation of smooth muscle cell proliferation (GO:0048661),4/46,0.001119244,0.053042083,0,0,9.65030525,65.57480953,GJA1;ID2;THBS1;FOXP1
positive regulation of gene expression (GO:0010628),13/482,0.001120607,0.053042083,0,0,2.880940918,19.57277963,BRAF;F3;CLU;THBS1;ACTB;ACTA2;AFDN;ACTA1;GJA1;LIN28A;ID2;DNMT3B;SLC38A2
negative regulation of cellular component organization (GO:0051129),5/80,0.001218461,0.054638335,0,0,6.778694158,45.48616746,CDC42;IMPACT;HSPA5;CLU;CRYAB
negative regulation of cellular response to growth factor stimulus (GO:0090288),5/80,0.001218461,0.054638335,0,0,6.778694158,45.48616746,NEDD4;SPRY4;LRP2;THBS1;SKIL
cellular component assembly (GO:0022607),9/261,0.001250525,0.054638335,0,0,3.67462406,24.56189124,CDC42;CALD1;PKP2;SLC2A1;FLNA;PARVA;YWHAZ;ACTB;AIF1L
positive regulation of endocytosis (GO:0045807),4/48,0.001314095,0.055980468,0,0,9.210722611,61.10952186,CDC42;RAB31;GPC3;CLU
hexose import across plasma membrane (GO:0140271),06-Feb,0.001439228,0.058391523,0,0,50.24619289,328.7934315,SLC2A1;SLC2A3
membrane raft assembly (GO:0001765),06-Feb,0.001439228,0.058391523,0,0,50.24619289,328.7934315,ANXA2;S100A10
DNA methylation (GO:0006306),23-Mar,0.001483757,0.05869224,0,0,15.13852041,98.59987994,DNMT3L;DNMT3A;DNMT3B
vascular transport (GO:0010232),5/84,0.001515527,0.05869224,0,0,6.434164165,41.77054118,SLC2A1;SLC1A3;SLC2A3;LRP2;SLC38A2
transport across blood-brain barrier (GO:0150104),5/86,0.001682565,0.063290432,0,0,6.274659539,40.07898541,SLC2A1;SLC1A3;SLC2A3;LRP2;SLC38A2
positive regulation of cell motility (GO:2000147),8/221,0.001708545,0.063290432,0,0,3.851830003,24.54429769,CAVIN1;HSPA5;PDPN;SEMA3E;LAMB1;ACTN4;F3;THBS1
ventricular cardiac muscle tissue development (GO:0003229),25-Mar,0.001899,0.068848843,0,0,13.76089981,86.23168732,ID2;TPM1;PKP2
regulation of morphogenesis of an epithelium (GO:1905330),07-Feb,0.002001732,0.069611247,0,0,40.19492386,249.7609083,GJA1;FOXP1
positive regulation of cytoplasmic translation (GO:2000767),07-Feb,0.002001732,0.069611247,0,0,40.19492386,249.7609083,LIN28A;PKM
regulation of cell motility (GO:2000145),6/133,0.002168859,0.072909016,0,0,4.815960181,29.53895186,BEX4;INPP5F;CAVIN1;TMSB4X;FLNA;AMOTL2
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),4/55,0.002182136,0.072909016,0,0,7.943690297,48.67457337,BEX3;PLAUR;SFN;THBS1
positive regulation of cellular component movement (GO:0051272),27-Mar,0.002380027,0.07799166,0,0,12.61288265,76.18992591,CAVIN1;PDPN;ACTN4
cell-cell adhesion mediated by cadherin (GO:0044331),08-Feb,0.002651521,0.079266531,0,0,33.49407783,198.7076941,AFDN;CTNND1
coronary vasculature morphogenesis (GO:0060977),08-Feb,0.002651521,0.079266531,0,0,33.49407783,198.7076941,SPRED1;LRP2
cytoplasmic sequestering of NF-kappaB (GO:0007253),08-Feb,0.002651521,0.079266531,0,0,33.49407783,198.7076941,TMSB4X;G3BP2
establishment of Golgi localization (GO:0051683),08-Feb,0.002651521,0.079266531,0,0,33.49407783,198.7076941,CDC42;YWHAZ
positive regulation of homotypic cell-cell adhesion (GO:0034112),08-Feb,0.002651521,0.079266531,0,0,33.49407783,198.7076941,PDPN;PLAUR
supramolecular fiber organization (GO:0097435),10/351,0.002797419,0.080959098,0,0,3.019441729,17.75147325,CDC42;COL18A1;MARCKS;TPM4;PLA2G1B;TPM2;TPM1;STMN2;RHOBTB3;ALDOA
neuron projection morphogenesis (GO:0048812),6/140,0.002803161,0.080959098,0,0,4.562756167,26.81535211,CDC42;IMPACT;MAP1B;S100A6;LRP2;ACTB
dicarboxylic acid transport (GO:0006835),29-Mar,0.002930148,0.083216212,0,0,11.64148352,67.90130694,GJA1;PDPN;SLC1A3
receptor-mediated endocytosis (GO:0006898),6/143,0.003113845,0.084869748,0,0,4.462161038,25.75513352,RAB31;INPP5F;NEDD4;LRP2;PDLIM7;HSP90B1
glucose metabolic process (GO:0006006),4/62,0.003381836,0.084869748,0,0,6.982493369,39.72575459,TPI1;PGK1;ENO1;ALDOA
actin-mediated cell contraction (GO:0070252),09-Feb,0.003386821,0.084869748,0,0,28.70775925,163.2858182,PDPN;PARVA
ATF6-mediated unfolded protein response (GO:0036500),09-Feb,0.003386821,0.084869748,0,0,28.70775925,163.2858182,HSPA5;HSP90B1
bone cell development (GO:0098751),09-Feb,0.003386821,0.084869748,0,0,28.70775925,163.2858182,ANXA2;FOXP1
"fructose 1,6-bisphosphate metabolic process (GO:0030388)",09-Feb,0.003386821,0.084869748,0,0,28.70775925,163.2858182,PFKL;ALDOA
L-ascorbic acid metabolic process (GO:0019852),09-Feb,0.003386821,0.084869748,0,0,28.70775925,163.2858182,SLC2A1;SLC2A3
positive regulation of ATP biosynthetic process (GO:2001171),09-Feb,0.003386821,0.084869748,0,0,28.70775925,163.2858182,TMSB4X;ENO1
cell junction assembly (GO:0034329),5/102,0.003542484,0.087483952,0,0,5.235412903,29.54305342,CDC42;CTNND1;PKP2;FLNA;ACTB
dicarboxylic acid biosynthetic process (GO:0043650),10-Feb,0.004205882,0.094042156,0,0,25.1180203,137.4275019,GLUD1;GLS
fructose 6-phosphate metabolic process (GO:0006002),10-Feb,0.004205882,0.094042156,0,0,25.1180203,137.4275019,PFKL;GFPT2
genetic imprinting (GO:0071514),10-Feb,0.004205882,0.094042156,0,0,25.1180203,137.4275019,DNMT3L;DNMT3A
modulation by symbiont of host process (GO:0044003),10-Feb,0.004205882,0.094042156,0,0,25.1180203,137.4275019,PGK1;ENO1
positive regulation of receptor recycling (GO:0001921),10-Feb,0.004205882,0.094042156,0,0,25.1180203,137.4275019,ANXA2;INPP5F
cell-cell junction assembly (GO:0007043),4/66,0.004236895,0.094042156,0,0,6.530686518,35.68317869,GJA1;CTNND1;PKP2;ACTB
actin filament bundle assembly (GO:0051017),3/33,0.004249558,0.094042156,0,0,10.0872449,55.08584333,CALD1;HSP90B1;AIF1L
apoptotic mitochondrial changes (GO:0008637),3/33,0.004249558,0.094042156,0,0,10.0872449,55.08584333,BNIP3;SFN;CLU
negative regulation of cellular process (GO:0048523),13/566,0.004497983,0.098263632,0,0,2.432713061,13.14668832,COL18A1;BNIP3;FHL1;ENO1;CLU;PTPN14;GJA1;IMPACT;PDPN;TXNIP;MYH9;ARID2;CRYAB
regulation of transmembrane transport (GO:0034762),3/34,0.004627025,0.09855563,0,0,9.761356155,52.4755005,NEDD4;SLC2A1;ACTB
ventricular cardiac muscle tissue morphogenesis (GO:0055010),3/34,0.004627025,0.09855563,0,0,9.761356155,52.4755005,TPM1;PKP2;LRP2
negative regulation of gene expression (GO:0010629),9/322,0.005082769,0.104846959,0,0,2.949251724,15.57765017,LARP1;LIN28A;SFMBT2;ID2;NOCT;ENC1;DNMT3A;DNMT3B;FOXP1
regulation of gene expression by genetic imprinting (GO:0006349),11-Feb,0.005106982,0.104846959,0,0,22.32600113,117.8175815,DNMT3L;DNMT3A
glutamine family amino acid biosynthetic process (GO:0009084),11-Feb,0.005106982,0.104846959,0,0,22.32600113,117.8175815,GLUD1;GLS
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),3/36,0.005441202,0.110378677,0,0,9.168831169,47.80404131,CDC42;FLNA;S100A10
positive regulation of cell migration (GO:0030335),8/269,0.005640695,0.113057415,0,0,3.135744519,16.23609509,HSPA5;GLIPR2;PDPN;SEMA3E;LAMB1;ACTN4;F3;THBS1
positive regulation of protein secretion (GO:0050714),4/72,0.005775696,0.113057415,0,0,5.952639517,30.68047898,GLUD1;PLA2G1B;ACSL4;MYH10
"phagocytosis, engulfment (GO:0006911)",3/37,0.005878455,0.113057415,0,0,8.898709484,45.70787663,CDC42;MYH9;THBS1
regulation of plasminogen activation (GO:0010755),12-Feb,0.006088424,0.113057415,0,0,20.09238579,102.4986136,ENO1;THBS1
glutamine metabolic process (GO:0006541),12-Feb,0.006088424,0.113057415,0,0,20.09238579,102.4986136,GLUD1;GLS
Golgi localization (GO:0051645),12-Feb,0.006088424,0.113057415,0,0,20.09238579,102.4986136,CDC42;YWHAZ
negative regulation of amyloid fibril formation (GO:1905907),12-Feb,0.006088424,0.113057415,0,0,20.09238579,102.4986136,CLU;CRYAB
regulation of protein-containing complex assembly (GO:0043254),5/116,0.006104039,0.113057415,0,0,4.571839881,23.31091831,CDC42;IMPACT;HSPA5;CLU;CRYAB
"negative regulation of transcription, DNA-templated (GO:0045892)",18/948,0.006634199,0.121555651,0,0,2.017929068,10.12095815,CBX5;PEG3;SFMBT2;DNMT3A;ENO1;GLI3;FOXP1;DNMT3L;IMPACT;NR6A1;ID2;RLIM;DNMT3B;FLNA;HDGF;LRRFIP1;CRYAB;SKIL
cytoskeleton organization (GO:0007010),5/120,0.007026753,0.123041474,0,0,4.411922905,21.87444854,CNN2;ABI2;DPYSL2;TPM1;RHOBTB3
regulation of nucleocytoplasmic transport (GO:0046822),13-Feb,0.007148536,0.123041474,0,0,18.26488233,90.2440009,NEDD4;PTPN14
glucose import (GO:0046323),13-Feb,0.007148536,0.123041474,0,0,18.26488233,90.2440009,SLC2A1;SLC2A3
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),13-Feb,0.007148536,0.123041474,0,0,18.26488233,90.2440009,SPRY4;ACTN4
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),13-Feb,0.007148536,0.123041474,0,0,18.26488233,90.2440009,SPRY4;ACTN4
positive regulation of purine nucleotide biosynthetic process (GO:1900373),13-Feb,0.007148536,0.123041474,0,0,18.26488233,90.2440009,TMSB4X;ENO1
carboxylic acid metabolic process (GO:0019752),3/40,0.007313833,0.124627709,0,0,8.175951462,40.20922981,GLUD1;SLC2A1;SLC2A3
negative regulation of blood vessel morphogenesis (GO:2000181),4/78,0.007648271,0.129036181,0,0,5.468329868,26.64867869,SPRED1;PGK1;SEMA3E;THBS1
regulation of release of cytochrome c from mitochondria (GO:0090199),3/41,0.007834243,0.130877937,0,0,7.960392052,38.6019396,BNIP3;PLAUR;CLU
regulation of lamellipodium organization (GO:1902743),14-Feb,0.008285672,0.134464624,0,0,16.74196277,80.24803624,CDC42;PDPN
cytoplasmic sequestering of transcription factor (GO:0042994),14-Feb,0.008285672,0.134464624,0,0,16.74196277,80.24803624,TMSB4X;G3BP2
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),14-Feb,0.008285672,0.134464624,0,0,16.74196277,80.24803624,SPRY4;THBS1
synapse organization (GO:0050808),5/126,0.008587255,0.138044174,0,0,4.191871858,19.94273043,CDC42;PPFIBP1;NEDD4;SEMA3E;PTPRF
negative regulation of transcription by RNA polymerase II (GO:0000122),14/684,0.008702191,0.138584426,0,0,2.160822912,10.2513338,CBX5;PEG3;DNMT3A;ENO1;GLI3;FOXP1;IMPACT;NR6A1;ID2;NEDD4;DNMT3B;HDGF;LRRFIP1;SKIL
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),12/547,0.008842724,0.13951854,0,0,2.310880104,10.92621148,DNMT3L;LARP1;CBX5;LIN28A;SFMBT2;ID2;ENC1;RLIM;ENO1;CRYAB;GLI3;FOXP1
"regulation of gene expression, epigenetic (GO:0040029)",4/82,0.009095632,0.141122204,0,0,5.186850756,24.37799591,DNMT3L;DNMT3A;DNMT3B;ACTB
regulation of amyloid fibril formation (GO:1905906),15-Feb,0.00949821,0.141122204,0,0,15.45333854,71.96081879,CLU;CRYAB
regulation of cytoplasmic translation (GO:2000765),15-Feb,0.00949821,0.141122204,0,0,15.45333854,71.96081879,LIN28A;PKM
regulation of endothelial cell chemotaxis (GO:2001026),15-Feb,0.00949821,0.141122204,0,0,15.45333854,71.96081879,TMSB4X;THBS1
integrated stress response signaling (GO:0140467),15-Feb,0.00949821,0.141122204,0,0,15.45333854,71.96081879,IMPACT;HSPA5
membrane raft organization (GO:0031579),15-Feb,0.00949821,0.141122204,0,0,15.45333854,71.96081879,ANXA2;S100A10
positive regulation of stress fiber assembly (GO:0051496),3/44,0.009524092,0.141122204,0,0,7.37680438,34.33113601,CDC42;TPM1;S100A10
neutrophil mediated immunity (GO:0002446),11/488,0.009918051,0.145692756,0,0,2.370355502,10.93539523,CNN2;PFKL;RAB31;PKM;ANXA2;ANXA3;PLA2G1B;PLAUR;SLC2A3;ALDOA;PRDX6
positive regulation of chemotaxis (GO:0050921),3/45,0.010130825,0.147546381,0,0,7.200801749,33.06732363,TMSB4X;THBS1;F3
negative regulation of cellular amide metabolic process (GO:0034249),4/86,0.010710848,0.148200613,0,0,4.932833021,22.37778809,LARP1;LIN28A;ENC1;CLU
positive regulation of endothelial cell migration (GO:0010595),4/86,0.010710848,0.148200613,0,0,4.932833021,22.37778809,ANXA3;TMSB4X;THBS1;FOXP1
interleukin-12-mediated signaling pathway (GO:0035722),3/46,0.010759542,0.148200613,0,0,7.032985287,31.873224,CDC42;CNN2;ANXA2
positive regulation of nucleocytoplasmic transport (GO:0046824),3/46,0.010759542,0.148200613,0,0,7.032985287,31.873224,NEDD4;FLNA;IPO5
regulation of ATP biosynthetic process (GO:2001169),16-Feb,0.010784552,0.148200613,0,0,14.34880348,64.99492239,TMSB4X;ENO1
epiboly involved in wound healing (GO:0090505),16-Feb,0.010784552,0.148200613,0,0,14.34880348,64.99492239,PDPN;FLNA
glutamine family amino acid catabolic process (GO:0009065),16-Feb,0.010784552,0.148200613,0,0,14.34880348,64.99492239,GLUD1;GLS
negative regulation of angiogenesis (GO:0016525),4/87,0.011141687,0.151883474,0,0,4.873154155,21.91487461,SPRED1;PGK1;SEMA3E;THBS1
cellular response to interleukin-12 (GO:0071349),3/48,0.012083468,0.154417041,0,0,6.719727891,29.6737608,CDC42;CNN2;ANXA2
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),17-Feb,0.012143124,0.154417041,0,0,13.39153976,59.06997727,GMFB;ABI2
cell communication by electrical coupling involved in cardiac conduction (GO:0086064),17-Feb,0.012143124,0.154417041,0,0,13.39153976,59.06997727,GJA1;PKP2
regulation of receptor recycling (GO:0001919),17-Feb,0.012143124,0.154417041,0,0,13.39153976,59.06997727,ANXA2;INPP5F
regulation of stem cell proliferation (GO:0072091),17-Feb,0.012143124,0.154417041,0,0,13.39153976,59.06997727,GJA1;EPCAM
ruffle organization (GO:0031529),17-Feb,0.012143124,0.154417041,0,0,13.39153976,59.06997727,TPM1;AIF1L
negative regulation of peptidyl-threonine phosphorylation (GO:0010801),17-Feb,0.012143124,0.154417041,0,0,13.39153976,59.06997727,SPRED1;CALM1
positive regulation of blood coagulation (GO:0030194),17-Feb,0.012143124,0.154417041,0,0,13.39153976,59.06997727,F3;THBS1
positive regulation of stem cell proliferation (GO:2000648),17-Feb,0.012143124,0.154417041,0,0,13.39153976,59.06997727,GJA1;EPCAM
adherens junction organization (GO:0034332),3/49,0.012778921,0.158943658,0,0,6.573314108,28.65937524,AFDN;CTNND1;ACTB
regulation of smooth muscle cell proliferation (GO:0048660),3/49,0.012778921,0.158943658,0,0,6.573314108,28.65937524,ID2;THBS1;FOXP1
response to glucose (GO:0009749),3/49,0.012778921,0.158943658,0,0,6.573314108,28.65937524,PFKL;LIN28A;THBS1
amino acid transport (GO:0006865),3/50,0.013496844,0.161729588,0,0,6.433130699,27.69655353,SLC7A7;PDPN;SLC38A2
regulation of cellular component movement (GO:0051270),3/50,0.013496844,0.161729588,0,0,6.433130699,27.69655353,INPP5F;PDPN;ACTN4
negative regulation of ERK1 and ERK2 cascade (GO:0070373),3/50,0.013496844,0.161729588,0,0,6.433130699,27.69655353,RPS6KA6;SPRED1;DUSP6
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),3/50,0.013496844,0.161729588,0,0,6.433130699,27.69655353,CDC42;FLNA;S100A10
acidic amino acid transport (GO:0015800),18-Feb,0.013572377,0.161729588,0,0,12.55393401,53.97838387,GJA1;SLC1A3
release of cytochrome c from mitochondria (GO:0001836),18-Feb,0.013572377,0.161729588,0,0,12.55393401,53.97838387,SFN;CLU
positive regulation of actin filament bundle assembly (GO:0032233),3/51,0.014237334,0.167847176,0,0,6.298788265,26.78173959,CDC42;TPM1;S100A10
negative regulation of MAPK cascade (GO:0043409),4/94,0.014471347,0.167847176,0,0,4.492535613,19.02851475,RPS6KA6;SPRED1;SPRY4;DUSP6
positive regulation of epithelial cell migration (GO:0010634),4/94,0.014471347,0.167847176,0,0,4.492535613,19.02851475,GLIPR2;ANXA3;THBS1;FOXP1
positive regulation of cell differentiation (GO:0045597),7/258,0.014964654,0.167847176,0,0,2.839682935,11.93253011,CDC42;GJA1;IMPACT;GLIPR2;ID2;NOCT;PDPN
ameboidal-type cell migration (GO:0001667),3/52,0.015000476,0.167847176,0,0,6.169929196,25.91168704,GPC3;SEMA3E;AMOTL2
sprouting angiogenesis (GO:0002040),3/52,0.015000476,0.167847176,0,0,6.169929196,25.91168704,SEMA3E;PARVA;THBS1
negative regulation of BMP signaling pathway (GO:0030514),3/52,0.015000476,0.167847176,0,0,6.169929196,25.91168704,LRP2;FSTL1;SKIL
negative regulation of protein metabolic process (GO:0051248),3/52,0.015000476,0.167847176,0,0,6.169929196,25.91168704,FLNA;CLU;CRYAB
protein homotetramerization (GO:0051289),3/52,0.015000476,0.167847176,0,0,6.169929196,25.91168704,ALDOA;GLS;ALDH9A1
regulation of cell-cell adhesion mediated by cadherin (GO:2000047),19-Feb,0.015070785,0.167847176,0,0,11.81487011,49.5633466,AFDN;EPCAM
IRE1-mediated unfolded protein response (GO:0036498),3/53,0.015786346,0.172860869,0,0,6.04622449,25.08342677,HSPA5;EDEM1;HDGF
negative regulation of cysteine-type endopeptidase activity (GO:2000117),3/53,0.015786346,0.172860869,0,0,6.04622449,25.08342677,BEX3;SFN;THBS1
regulation of angiogenesis (GO:0045765),6/203,0.016190276,0.172860869,0,0,3.093658768,12.75622079,SPRED1;ANXA3;PGK1;SEMA3E;F3;THBS1
regulation of potassium ion transmembrane transport (GO:1901379),3/54,0.016595009,0.172860869,0,0,5.927370948,24.29423842,NEDD4;FHL1;FLNA
regulation of proteolysis (GO:0030162),3/54,0.016595009,0.172860869,0,0,5.927370948,24.29423842,PERP;PLAUR;CLN6
protein targeting to lysosome (GO:0006622),20-Feb,0.016636844,0.172860869,0,0,11.15792442,45.70437045,NEDD4;CLU
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),20-Feb,0.016636844,0.172860869,0,0,11.15792442,45.70437045,SPRY4;THBS1
embryonic digestive tract development (GO:0048566),20-Feb,0.016636844,0.172860869,0,0,11.15792442,45.70437045,ID2;GLI3
glucose transmembrane transport (GO:1904659),20-Feb,0.016636844,0.172860869,0,0,11.15792442,45.70437045,SLC2A1;SLC2A3
myeloid cell development (GO:0061515),20-Feb,0.016636844,0.172860869,0,0,11.15792442,45.70437045,ANXA2;FOXP1
positive regulation of protein processing (GO:0010954),20-Feb,0.016636844,0.172860869,0,0,11.15792442,45.70437045,MYH9;ENO1
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),4/100,0.017778332,0.182495644,0,0,4.210470085,16.96724663,SPRED1;PEG10;SKIL;THBS1
positive regulation of translation (GO:0045727),4/100,0.017778332,0.182495644,0,0,4.210470085,16.96724663,LARP1;LIN28A;PKM;THBS1
Rho protein signal transduction (GO:0007266),3/56,0.018280935,0.186531217,0,0,5.703118983,22.82329228,CDC42;PDPN;ARHGAP29
regulation of cell death (GO:0010941),4/102,0.018976694,0.191338973,0,0,4.124123496,16.35026778,IMPACT;BNIP3;CLU;CRYAB
regulation of protein catabolic process (GO:0042176),4/102,0.018976694,0.191338973,0,0,4.124123496,16.35026778,NEDD4;ODC1;GPC3;FLNA
cell projection assembly (GO:0030031),22-Feb,0.019966017,0.196659494,0,0,10.04111675,39.29815577,CDC42;PARVA
regulation of vacuole organization (GO:0044088),22-Feb,0.019966017,0.196659494,0,0,10.04111675,39.29815577,ANXA2;ENO1
glutamate metabolic process (GO:0006536),22-Feb,0.019966017,0.196659494,0,0,10.04111675,39.29815577,GLUD1;GLS
osteoclast differentiation (GO:0030316),22-Feb,0.019966017,0.196659494,0,0,10.04111675,39.29815577,ANXA2;FOXP1
hexose transmembrane transport (GO:0008645),23-Feb,0.021726236,0.209161055,0,0,9.562484892,36.61699897,SLC2A1;SLC2A3
negative regulation of smoothened signaling pathway (GO:0045879),23-Feb,0.021726236,0.209161055,0,0,9.562484892,36.61699897,GPC3;GLI3
nucleotide metabolic process (GO:0009117),23-Feb,0.021726236,0.209161055,0,0,9.562484892,36.61699897,ENPP3;NUDT5
positive regulation of epithelial cell apoptotic process (GO:1904037),23-Feb,0.021726236,0.209161055,0,0,9.562484892,36.61699897,PLA2G1B;THBS1
response to calcium ion (GO:0051592),4/107,0.022187661,0.212403223,0,0,3.922927558,14.93936716,NEDD4;BRAF;CALM1;THBS1
regulation of gene expression (GO:0010468),18/1079,0.022344041,0.212705288,0,0,1.756499914,6.676799739,PEG3;SFMBT2;JMJD1C;BRAF;F3;CLU;FOXP1;ACTA2;AFDN;ACTA1;GJA1;LARP1;ID2;ESRP1;NOCT;RLIM;DNMT3B;SLC38A2
neutrophil degranulation (GO:0043312),10/481,0.022568322,0.213646781,0,0,2.171446545,8.232405604,CNN2;PFKL;RAB31;PKM;ANXA2;ANXA3;PLAUR;SLC2A3;ALDOA;PRDX6
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),4/108,0.02286718,0.215279972,0,0,3.885009862,14.67777153,SPRED1;PEG10;LRP2;SKIL
"wound healing, spreading of cells (GO:0044319)",24-Feb,0.023548319,0.218077913,0,0,9.127365021,34.21576083,PDPN;FLNA
neuromuscular junction development (GO:0007528),24-Feb,0.023548319,0.218077913,0,0,9.127365021,34.21576083,PPFIBP1;NEDD4
positive regulation of lamellipodium assembly (GO:0010592),24-Feb,0.023548319,0.218077913,0,0,9.127365021,34.21576083,CDC42;ABI2
neutrophil activation involved in immune response (GO:0002283),10/485,0.02372579,0.218533762,0,0,2.152715121,8.053721973,CNN2;PFKL;RAB31;PKM;ANXA2;ANXA3;PLAUR;SLC2A3;ALDOA;PRDX6
actin cytoskeleton reorganization (GO:0031532),3/63,0.024905185,0.22688067,0,0,5.035969388,18.59621975,MYH9;FLNA;PARVA
regulation of cardiac muscle cell action potential (GO:0098901),25-Feb,0.025430873,0.22688067,0,0,8.73008166,32.05503844,PKP2;CALM1
regulation of microtubule depolymerization (GO:0031114),25-Feb,0.025430873,0.22688067,0,0,8.73008166,32.05503844,MAP1B;STMN2
response to hexose (GO:0009746),25-Feb,0.025430873,0.22688067,0,0,8.73008166,32.05503844,PFKL;THBS1
outflow tract septum morphogenesis (GO:0003148),25-Feb,0.025430873,0.22688067,0,0,8.73008166,32.05503844,PARVA;LRP2
positive regulation of release of cytochrome c from mitochondria (GO:0090200),25-Feb,0.025430873,0.22688067,0,0,8.73008166,32.05503844,BNIP3;PLAUR
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),3/64,0.025943489,0.230248461,0,0,4.953161593,18.088127,PLAUR;ENO1;CLU
purine-containing compound biosynthetic process (GO:0072522),26-Feb,0.027372527,0.236765413,0,0,8.365905245,30.10232929,PRPS2;ADK
regulation of potassium ion transmembrane transporter activity (GO:1901016),26-Feb,0.027372527,0.236765413,0,0,8.365905245,30.10232929,NEDD4;FHL1
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),26-Feb,0.027372527,0.236765413,0,0,8.365905245,30.10232929,SFN;YWHAZ
regulation of synapse organization (GO:0050807),26-Feb,0.027372527,0.236765413,0,0,8.365905245,30.10232929,NEDD4;YWHAZ
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),26-Feb,0.027372527,0.236765413,0,0,8.365905245,30.10232929,SFN;YWHAZ
positive regulation of angiogenesis (GO:0045766),4/116,0.028759285,0.24750415,0,0,3.606043956,12.79710935,PKM;ANXA3;F3;THBS1
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),3/68,0.030325923,0.256233962,0,0,4.647409733,16.24619364,SPRED1;PEG10;SKIL
cellular response to acid chemical (GO:0071229),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,CAPN2;IPO5
regulation of microtubule polymerization or depolymerization (GO:0031110),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,MAP1B;STMN2
regulation of muscle contraction (GO:0006937),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,TPM1;ENO1
glycerophospholipid catabolic process (GO:0046475),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,INPP5F;PRDX6
sarcomere organization (GO:0045214),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,KRT19;TPM1
L-amino acid transport (GO:0015807),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,SLC1A3;SLC38A2
macromolecule catabolic process (GO:0009057),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,NEDD4;CLN6
positive regulation of fibroblast proliferation (GO:0048146),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,PLA2G1B;S100A6
positive regulation of protein import into nucleus (GO:0042307),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,FLNA;IPO5
protein depolymerization (GO:0051261),28-Feb,0.031427757,0.256233962,0,0,7.721593128,26.71720479,STMN2;DSTN
regulation of ERK1 and ERK2 cascade (GO:0070372),6/238,0.032120005,0.260630897,0,0,2.622252993,9.016030149,RPS6KA6;SPRED1;GLIPR2;BRAF;YWHAZ;DUSP6
positive regulation of cell-substrate adhesion (GO:0010811),3/70,0.032654076,0.262181225,0,0,4.508224185,15.42617663,CDC42;FLNA;S100A10
protein homooligomerization (GO:0051260),4/121,0.032859042,0.262181225,0,0,3.451062897,11.78720306,G3BP2;ALDOA;GLS;ALDH9A1
regulation of translation (GO:0006417),5/178,0.032891613,0.262181225,0,0,2.924140397,9.984587257,IMPACT;LARP1;LIN28A;ENC1;THBS1
axonogenesis (GO:0007409),6/240,0.033257009,0.262181225,0,0,2.599574864,8.847626357,MAP1B;S100A6;SEMA3E;EMB;ACTB;PDLIM7
negative regulation of mRNA catabolic process (GO:1902373),2/29,0.033538695,0.262181225,0,0,7.435232187,25.24302534,LARP1;NOCT
protein stabilization (GO:0050821),5/179,0.033574086,0.262181225,0,0,2.90718687,9.866994418,CTNND1;FLNA;PARVA;CLU;CRYAB
protein tetramerization (GO:0051262),3/71,0.033852191,0.262181225,0,0,4.441701681,15.03849831,ALDOA;GLS;ALDH9A1
response to metal ion (GO:0010038),3/71,0.033852191,0.262181225,0,0,4.441701681,15.03849831,NEDD4;CALM1;THBS1
myeloid leukocyte differentiation (GO:0002573),3/71,0.033852191,0.262181225,0,0,4.441701681,15.03849831,CDC42;MYH9;FOXP1
cell morphogenesis involved in differentiation (GO:0000904),3/72,0.035072911,0.262181225,0,0,4.377107365,14.66473759,ABI2;LAMB1;PARVA
negative regulation of supramolecular fiber organization (GO:1902904),3/72,0.035072911,0.262181225,0,0,4.377107365,14.66473759,STMN2;CLU;CRYAB
cell projection organization (GO:0030030),2/30,0.035703458,0.262181225,0,0,7.169325598,23.891833,CDC42;PARVA
regulation of protein localization to membrane (GO:1905475),2/30,0.035703458,0.262181225,0,0,7.169325598,23.891833,GPC3;ACTB
Golgi to plasma membrane protein transport (GO:0043001),2/30,0.035703458,0.262181225,0,0,7.169325598,23.891833,KRT18;RAB31
heterotypic cell-cell adhesion (GO:0034113),2/30,0.035703458,0.262181225,0,0,7.169325598,23.891833,PKP2;PARVA
maintenance of blood-brain barrier (GO:0035633),2/30,0.035703458,0.262181225,0,0,7.169325598,23.891833,GJA1;ACTB
"negative regulation of gene expression, epigenetic (GO:0045814)",2/30,0.035703458,0.262181225,0,0,7.169325598,23.891833,DNMT3A;DNMT3B
plasma membrane invagination (GO:0099024),2/30,0.035703458,0.262181225,0,0,7.169325598,23.891833,CDC42;MYH9
positive regulation of protein import (GO:1904591),2/30,0.035703458,0.262181225,0,0,7.169325598,23.891833,FLNA;IPO5
ubiquitin-dependent ERAD pathway (GO:0030433),3/73,0.036316158,0.262181225,0,0,4.314358601,14.30422361,HSPA5;EDEM1;HSP90B1
neurotransmitter transport (GO:0006836),3/73,0.036316158,0.262181225,0,0,4.314358601,14.30422361,SLC1A3;SLC38A2;GLS
regulation of stress fiber assembly (GO:0051492),3/74,0.037581854,0.262181225,0,0,4.253377407,13.95632634,CDC42;TPM1;S100A10
cardiac muscle cell action potential involved in contraction (GO:0086002),2/31,0.037920776,0.262181225,0,0,6.921757395,22.64976304,GJA1;PKP2
positive regulation of locomotion (GO:0040017),2/31,0.037920776,0.262181225,0,0,6.921757395,22.64976304,CAVIN1;THBS1
positive regulation of RNA splicing (GO:0033120),2/31,0.037920776,0.262181225,0,0,6.921757395,22.64976304,SLC38A2;PRDX6
integrin-mediated signaling pathway (GO:0007229),3/75,0.038869913,0.262181225,0,0,4.194090136,13.6204536,CDC42;ZYX;MYH9
plasma membrane bounded cell projection organization (GO:0120036),4/128,0.039144795,0.262181225,0,0,3.255086849,10.54806928,NEDD4;TPM1;STMN2;LAMB1
regulation of BMP signaling pathway (GO:0030510),3/76,0.040180243,0.262181225,0,0,4.136427174,13.29604827,LRP2;FSTL1;SKIL
regulation of cell division (GO:0051302),3/76,0.040180243,0.262181225,0,0,4.136427174,13.29604827,TXNIP;SFN;CALM1
cell morphogenesis involved in neuron differentiation (GO:0048667),3/76,0.040180243,0.262181225,0,0,4.136427174,13.29604827,MAP1B;S100A6;ACTB
regulation of epithelial to mesenchymal transition (GO:0010717),3/76,0.040180243,0.262181225,0,0,4.136427174,13.29604827,SPRED1;GLIPR2;PDPN
cardiac muscle tissue morphogenesis (GO:0055008),2/32,0.040189402,0.262181225,0,0,6.690693739,21.5049063,TPM1;PKP2
response to amino acid (GO:0043200),2/32,0.040189402,0.262181225,0,0,6.690693739,21.5049063,CAPN2;IPO5
negative regulation of cell-matrix adhesion (GO:0001953),2/32,0.040189402,0.262181225,0,0,6.690693739,21.5049063,SEMA3E;THBS1
negative regulation of chemotaxis (GO:0050922),2/32,0.040189402,0.262181225,0,0,6.690693739,21.5049063,SEMA3E;THBS1
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/32,0.040189402,0.262181225,0,0,6.690693739,21.5049063,STRN3;FOXP1
positive regulation of lamellipodium organization (GO:1902745),2/32,0.040189402,0.262181225,0,0,6.690693739,21.5049063,CDC42;ABI2
cellular response to UV (GO:0034644),3/77,0.041512749,0.262181225,0,0,4.08032267,12.98258583,IMPACT;NEDD4;CUL4B
actin filament bundle organization (GO:0061572),2/33,0.042508106,0.262181225,0,0,6.474537416,20.44698083,CALD1;AIF1L
regulation of sprouting angiogenesis (GO:1903670),2/33,0.042508106,0.262181225,0,0,6.474537416,20.44698083,PKM;THBS1
RNA stabilization (GO:0043489),2/33,0.042508106,0.262181225,0,0,6.474537416,20.44698083,LARP1;NOCT
neuron projection extension (GO:1990138),2/33,0.042508106,0.262181225,0,0,6.474537416,20.44698083,IMPACT;MAP1B
positive regulation of ATP metabolic process (GO:1903580),2/33,0.042508106,0.262181225,0,0,6.474537416,20.44698083,TMSB4X;ENO1
negative regulation of apoptotic signaling pathway (GO:2001234),3/78,0.04286733,0.262181225,0,0,4.025714286,12.67957202,PLAUR;CLU;THBS1
negative regulation of nucleic acid-templated transcription (GO:1903507),9/464,0.043081054,0.262181225,0,0,2.014042799,6.333503905,DNMT3L;CBX5;SFMBT2;ID2;RLIM;ENO1;CRYAB;GLI3;FOXP1
axon development (GO:0061564),3/79,0.04424388,0.262181225,0,0,3.972542965,12.38654079,MAP1B;S100A6;ACTB
regulation of programmed cell death (GO:0043067),5/194,0.044874581,0.262181225,0,0,2.674412262,8.301064809,LGALS1;PERP;BNIP3;ACTN4;CLU
cellular response to amino acid stimulus (GO:0071230),2/34,0.044875677,0.262181225,0,0,6.271890863,19.467067,CAPN2;IPO5
regulation of lamellipodium assembly (GO:0010591),2/34,0.044875677,0.262181225,0,0,6.271890863,19.467067,CDC42;ABI2
negative regulation of mitochondrion organization (GO:0010823),2/34,0.044875677,0.262181225,0,0,6.271890863,19.467067,BNIP3;CLU
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),2/34,0.044875677,0.262181225,0,0,6.271890863,19.467067,SFN;YWHAZ
protein localization to membrane (GO:0072657),5/195,0.045699599,0.262181225,0,0,2.66020076,8.208490392,ARL5C;PKP2;FLNA;BRAF;S100A10
regulation of interleukin-8 production (GO:0032677),3/81,0.047062444,0.262181225,0,0,3.870290424,11.82869109,PLA2G1B;TMSB4X;F3
protein localization to plasma membrane (GO:0072659),4/136,0.047112486,0.262181225,0,0,3.056565657,9.338471993,AFDN;PKP2;FLNA;S100A10
organic substance transport (GO:0071702),4/136,0.047112486,0.262181225,0,0,3.056565657,9.338471993,TXNIP;MYH9;LRP2;HSP90B1
regulation of muscle cell differentiation (GO:0051147),2/35,0.047290926,0.262181225,0,0,6.081525919,18.55739228,CDC42;ID2
semaphorin-plexin signaling pathway (GO:0071526),2/35,0.047290926,0.262181225,0,0,6.081525919,18.55739228,FLNA;SEMA3E
peptidyl-tyrosine dephosphorylation (GO:0035335),2/35,0.047290926,0.262181225,0,0,6.081525919,18.55739228,PTPRF;DUSP6
cell-cell junction organization (GO:0045216),3/82,0.048504223,0.262181225,0,0,3.821105657,11.56306467,AFDN;CTNND1;PKP2
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,PRPS2
5-phosphoribose 1-diphosphate metabolic process (GO:0046391),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,PRPS2
pulmonary artery morphogenesis (GO:0061156),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,LRP2
amino-acid betaine biosynthetic process (GO:0006578),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ALDH9A1
pyrimidine nucleotide metabolic process (GO:0006220),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ENPP3
anion homeostasis (GO:0055081),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,GLS
carnitine biosynthetic process (GO:0045329),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ALDH9A1
cell migration involved in gastrulation (GO:0042074),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,GPC3
regulation of endothelial tube morphogenesis (GO:1901509),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,FOXP1
regulation of heart growth (GO:0060420),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,DUSP6
chronic inflammatory response (GO:0002544),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,THBS1
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ANXA2
copper ion import (GO:0015677),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,STEAP2
coronary artery morphogenesis (GO:0060982),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,LRP2
disaccharide biosynthetic process (GO:0046351),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,SLC2A1
regulation of plasma membrane organization (GO:1903729),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,MYH9
regulation of sodium:proton antiporter activity (GO:0032415),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ACTN4
female genitalia development (GO:0030540),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,LRP2
folate transmembrane transport (GO:0098838),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,LRP2
glutamate catabolic process (GO:0006538),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,GLUD1
heart field specification (GO:0003128),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,LRP2
His-Purkinje system development (GO:0003164),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ID2
ribose phosphate metabolic process (GO:0019693),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,NUDT5
secondary heart field specification (GO:0003139),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,LRP2
L-aspartate transmembrane transport (GO:0070778),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,SLC1A3
lymph node development (GO:0048535),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,PDPN
maintenance of animal organ identity (GO:0048496),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,PKP2
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,EDEM1
mesonephric duct development (GO:0072177),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,GPC3
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,EDEM1
negative regulation of B cell differentiation (GO:0045578),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ID2
negative regulation of cGMP-mediated signaling (GO:0010754),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,THBS1
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,PLAUR
negative regulation of gonadotropin secretion (GO:0032277),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,GJA1
negative regulation of IRE1-mediated unfolded protein response (GO:1903895),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,HSPA5
negative regulation of mast cell activation involved in immune response (GO:0033007),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ENPP3
negative regulation of plasminogen activation (GO:0010757),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,THBS1
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,TMSB4X
negative regulation of transcription by RNA polymerase I (GO:0016479),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,FLNA
negative regulation of tubulin deacetylation (GO:1904428),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,BEX4
nucleoside triphosphate catabolic process (GO:0009143),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ENPP3
pentose catabolic process (GO:0019323),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,NUDT5
positive regulation of dendritic cell differentiation (GO:2001200),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,LGALS1
positive regulation of low-density lipoprotein receptor activity (GO:1905599),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,ANXA2
positive regulation of phospholipase A2 activity (GO:0032430),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,PLA2G1B
positive regulation of protein catabolic process in the vacuole (GO:1904352),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,LRP2
positive regulation of translation in response to stress (GO:0032056),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,IMPACT
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),05-Jan,0.048774324,0.262181225,0,0,24.99621212,75.50233979,EDEM1
regulation of protein import into nucleus (GO:0042306),2/36,0.049752678,0.263287464,0,0,5.902358913,17.71115519,FLNA;IPO5
establishment of protein localization to plasma membrane (GO:0061951),2/36,0.049752678,0.263287464,0,0,5.902358913,17.71115519,AFDN;RAB31
regulation of sodium ion transport (GO:0002028),2/36,0.049752678,0.263287464,0,0,5.902358913,17.71115519,NEDD4;PKP2
macrophage activation (GO:0042116),2/36,0.049752678,0.263287464,0,0,5.902358913,17.71115519,CLU;FOXP1
membrane assembly (GO:0071709),2/36,0.049752678,0.263287464,0,0,5.902358913,17.71115519,ANXA2;S100A10
response to insulin (GO:0032868),3/84,0.051452162,0.271156516,0,0,3.726379441,11.05655087,PKM;RAB31;PLA2G1B
regulation of actin cytoskeleton reorganization (GO:2000249),2/37,0.05225978,0.271156516,0,0,5.733430022,16.92238052,CDC42;SEMA3E
regulation of protein autophosphorylation (GO:0031952),2/37,0.05225978,0.271156516,0,0,5.733430022,16.92238052,IMPACT;CALM1
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),2/37,0.05225978,0.271156516,0,0,5.733430022,16.92238052,GJA1;TPM1
glutamine family amino acid metabolic process (GO:0009064),2/37,0.05225978,0.271156516,0,0,5.733430022,16.92238052,GLUD1;GLS
Ras protein signal transduction (GO:0007265),4/142,0.053635938,0.271156516,0,0,2.922779636,8.550696923,ABI2;PDPN;G3BP2;ARHGAP29
regulation of phosphoprotein phosphatase activity (GO:0043666),2/38,0.054811097,0.271156516,0,0,5.573886069,16.18579937,CALM1;HSP90B1
positive regulation of insulin secretion (GO:0032024),2/38,0.054811097,0.271156516,0,0,5.573886069,16.18579937,GLUD1;ACSL4
positive regulation of potassium ion transport (GO:0043268),2/38,0.054811097,0.271156516,0,0,5.573886069,16.18579937,FHL1;FLNA
positive regulation of signaling (GO:0023056),2/38,0.054811097,0.271156516,0,0,5.573886069,16.18579937,INPP5F;ANXA2
negative regulation of cell migration (GO:0030336),4/144,0.055914106,0.271156516,0,0,2.880732601,8.3078559,AFDN;GJA1;TPM1;ARID2
ERAD pathway (GO:0036503),3/87,0.056033052,0.271156516,0,0,3.592747813,10.35362933,HSPA5;EDEM1;HSP90B1
regulation of intracellular transport (GO:0032386),2/39,0.057405509,0.271156516,0,0,5.422966113,15.49674936,INPP5F;CRYAB
regulation of ion transmembrane transporter activity (GO:0032412),2/39,0.057405509,0.271156516,0,0,5.422966113,15.49674936,NEDD4;FHL1
regulation of peptidyl-threonine phosphorylation (GO:0010799),2/39,0.057405509,0.271156516,0,0,5.422966113,15.49674936,SPRED1;CALM1
endothelial cell migration (GO:0043542),2/39,0.057405509,0.271156516,0,0,5.422966113,15.49674936,MYH9;FSTL1
post-translational protein modification (GO:0043687),7/345,0.05765565,0.271156516,0,0,2.099374384,5.990075715,LGALS1;FEM1B;GPC3;LAMB1;FSTL1;HSP90B1;CUL4B
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,PKP2
regulation of cell cycle checkpoint (GO:1901976),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,FEM1B
regulation of long-chain fatty acid import across plasma membrane (GO:0010746),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,THBS1
regulation of nitric oxide mediated signal transduction (GO:0010749),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,THBS1
regulation of protein depolymerization (GO:1901879),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,MAP1B
foam cell differentiation (GO:0090077),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,SOAT1
ruffle assembly (GO:0097178),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,AIF1L
skeletal muscle thin filament assembly (GO:0030240),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,ACTA1
macrophage derived foam cell differentiation (GO:0010742),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,SOAT1
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,PTPRF
mitochondrial protein catabolic process (GO:0035694),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,BNIP3
ventricular compact myocardium morphogenesis (GO:0003223),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,LRP2
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,GMFB
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,THBS1
negative regulation of cellular response to hypoxia (GO:1900038),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,ENO1
negative regulation of histone H3-K9 methylation (GO:0051573),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,DNMT3B
negative regulation of lens fiber cell differentiation (GO:1902747),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,SPRED1
negative regulation of mast cell activation (GO:0033004),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,ENPP3
negative regulation of trophoblast cell migration (GO:1901164),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,GJA1
nephric duct morphogenesis (GO:0072178),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,GPC3
peroxisome proliferator activated receptor signaling pathway (GO:0035357),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,ACTN4
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,THBS1
positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,TPM1
positive regulation of lipoprotein particle clearance (GO:0010986),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,ANXA2
positive regulation of plasminogen activation (GO:0010756),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,ENO1
positive regulation of receptor binding (GO:1900122),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,ANXA2
positive regulation of tau-protein kinase activity (GO:1902949),06-Jan,0.058241364,0.271156516,0,0,19.9959596,56.85170146,CLU
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3/89,0.059191351,0.272130669,0,0,3.508839582,9.919418808,BEX3;SFN;THBS1
regulation of endothelial cell migration (GO:0010594),3/89,0.059191351,0.272130669,0,0,3.508839582,9.919418808,ANXA3;THBS1;FOXP1
protein import (GO:0017038),3/89,0.059191351,0.272130669,0,0,3.508839582,9.919418808,POM121;CLU;IPO5
stem cell differentiation (GO:0048863),2/40,0.060041916,0.272130669,0,0,5.279989313,14.85109117,DNMT3L;EPCAM
negative regulation of blood coagulation (GO:0030195),2/40,0.060041916,0.272130669,0,0,5.279989313,14.85109117,PLAUR;F3
positive regulation of cation channel activity (GO:2001259),2/40,0.060041916,0.272130669,0,0,5.279989313,14.85109117,TMSB4X;CALM1
positive regulation of intracellular protein transport (GO:0090316),4/148,0.060624817,0.272130669,0,0,2.80014245,7.848941947,FLNA;SFN;YWHAZ;IPO5
cellular amino acid catabolic process (GO:0009063),3/90,0.060801375,0.272130669,0,0,3.46833216,9.711825593,GLUD1;GLDC;GLS
negative regulation of translation (GO:0017148),3/90,0.060801375,0.272130669,0,0,3.46833216,9.711825593,LARP1;LIN28A;ENC1
positive regulation of transport (GO:0051050),3/91,0.062431781,0.272130669,0,0,3.428745362,9.510245253,ANXA2;GPC3;ACTB
carboxylic acid transmembrane transport (GO:1905039),2/41,0.062719237,0.272130669,0,0,5.144344657,14.2451383,SLC7A7;SLC38A2
regulation of protein dephosphorylation (GO:0035304),2/41,0.062719237,0.272130669,0,0,5.144344657,14.2451383,CALM1;HSP90B1
import into cell (GO:0098657),2/41,0.062719237,0.272130669,0,0,5.144344657,14.2451383,SLC1A3;LRP2
cellular response to organic cyclic compound (GO:0071407),4/150,0.063056878,0.272130669,0,0,2.761503337,7.632016843,IMPACT;LARP1;ACTB;HSP90B1
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),2/42,0.065436403,0.272130669,0,0,5.015482234,13.67559778,FEM1B;THBS1
positive regulation of epithelial to mesenchymal transition (GO:0010718),2/42,0.065436403,0.272130669,0,0,5.015482234,13.67559778,GLIPR2;PDPN
negative regulation of protein phosphorylation (GO:0001933),4/152,0.065539711,0.272130669,0,0,2.723908524,7.422920508,SPRED1;IMPACT;SFN;CALM1
negative regulation of cell death (GO:0060548),3/94,0.067443725,0.272130669,0,0,3.315205203,8.939323971,IMPACT;BNIP3;CLU
negative regulation of cellular protein metabolic process (GO:0032269),3/94,0.067443725,0.272130669,0,0,3.315205203,8.939323971,LARP1;LIN28A;ENC1
aldehyde biosynthetic process (GO:0046184),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,TPI1
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,FLNA
autophagosome membrane docking (GO:0016240),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,CALM1
bleb assembly (GO:0032060),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,PMP22
regulation of cGMP-mediated signaling (GO:0010752),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,THBS1
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,PKP2
Cdc42 protein signal transduction (GO:0032488),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,CDC42
regulation of defense response to bacterium (GO:1900424),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,FOXP1
regulation of lens fiber cell differentiation (GO:1902746),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,SPRED1
regulation of lysosomal protein catabolic process (GO:1905165),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,LRP2
coronary vasculature development (GO:0060976),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,GPC3
desmosome organization (GO:0002934),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,PKP2
endothelial cell morphogenesis (GO:0001886),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,COL18A1
gap junction assembly (GO:0016264),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,GJA1
regulation of transforming growth factor beta1 production (GO:0032908),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,THBS1
regulation of tubulin deacetylation (GO:0090043),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,BEX4
glutamine transport (GO:0006868),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,SLC38A2
glyceraldehyde-3-phosphate metabolic process (GO:0019682),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,TPI1
ribose phosphate biosynthetic process (GO:0046390),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,PRPS2
intermediate filament bundle assembly (GO:0045110),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,PKP2
serine transport (GO:0032329),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,SLC38A2
smooth muscle cell migration (GO:0014909),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,PARVA
T cell apoptotic process (GO:0070231),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,GLI3
miRNA catabolic process (GO:0010587),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,LIN28A
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,CALM1
negative regulation of axon regeneration (GO:0048681),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,INPP5F
negative regulation of intracellular transport (GO:0032387),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,CRYAB
negative regulation of lymphocyte differentiation (GO:0045620),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,ID2
neuron projection arborization (GO:0140058),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,LRP2
nose development (GO:0043584),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,GLI3
nucleobase catabolic process (GO:0046113),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,DPYSL2
positive regulation of B cell receptor signaling pathway (GO:0050861),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,FOXP1
positive regulation of gliogenesis (GO:0014015),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,LRP2
positive regulation of integrin-mediated signaling pathway (GO:2001046),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,FLNA
positive regulation of pinocytosis (GO:0048549),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,CDC42
positive regulation of vesicle fusion (GO:0031340),07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,ANXA2
"posttranslational protein targeting to membrane, translocation (GO:0031204)",07-Jan,0.067614655,0.272130669,0,0,16.66245791,44.88750406,HSPA5
cellular response to glucose starvation (GO:0042149),2/43,0.068192368,0.272130669,0,0,4.892905782,13.13951987,IMPACT;HSPA5
development of primary male sexual characteristics (GO:0046546),2/43,0.068192368,0.272130669,0,0,4.892905782,13.13951987,LRP2;UTF1
male gonad development (GO:0008584),2/43,0.068192368,0.272130669,0,0,4.892905782,13.13951987,LRP2;UTF1
myofibril assembly (GO:0030239),2/43,0.068192368,0.272130669,0,0,4.892905782,13.13951987,KRT19;TPM1
positive regulation of peptide hormone secretion (GO:0090277),2/43,0.068192368,0.272130669,0,0,4.892905782,13.13951987,GLUD1;ACSL4
cardiac ventricle morphogenesis (GO:0003208),2/44,0.070986099,0.275851122,0,0,4.776166304,12.6342552,TPM1;PKP2
mitotic spindle assembly (GO:0090307),2/44,0.070986099,0.275851122,0,0,4.776166304,12.6342552,STAG2;FLNA
mRNA stabilization (GO:0048255),2/44,0.070986099,0.275851122,0,0,4.776166304,12.6342552,LARP1;NOCT
positive regulation of receptor-mediated endocytosis (GO:0048260),2/44,0.070986099,0.275851122,0,0,4.776166304,12.6342552,ANXA2;CLU
amino acid transmembrane transport (GO:0003333),2/45,0.07381658,0.275851122,0,0,4.664856569,12.15741814,SLC7A7;SLC38A2
zymogen activation (GO:0031638),2/45,0.07381658,0.275851122,0,0,4.664856569,12.15741814,PERP;PGK1
positive regulation of RNA metabolic process (GO:0051254),2/45,0.07381658,0.275851122,0,0,4.664856569,12.15741814,LIN28A;SLC38A2
protein transport (GO:0015031),7/369,0.076441331,0.275851122,0,0,1.957772215,5.033886072,RAB31;ARL5C;TXNIP;MYH9;LRP2;CLU;HSP90B1
alpha-amino acid metabolic process (GO:1901605),2/46,0.076682813,0.275851122,0,0,4.558606368,11.70685527,GLUD1;GLS
regulation of fibroblast proliferation (GO:0048145),2/46,0.076682813,0.275851122,0,0,4.558606368,11.70685527,PLA2G1B;S100A6
pyrimidine nucleobase catabolic process (GO:0006208),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,DPYSL2
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,PDK1
regulation of acyl-CoA biosynthetic process (GO:0050812),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,PDK1
regulation of alpha-beta T cell differentiation (GO:0046637),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,GLI3
atrial cardiac muscle cell to AV node cell signaling (GO:0086026),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,GJA1
basic amino acid transport (GO:0015802),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,SLC7A7
cardiac muscle hypertrophy (GO:0003300),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,INPP5F
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,CALM1
regulation of myeloid leukocyte differentiation (GO:0002761),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,FOXP1
regulation of positive chemotaxis (GO:0050926),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,F3
entry of bacterium into host cell (GO:0035635),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,CTNND1
regulation of RNA biosynthetic process (GO:2001141),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ACTN4
folic acid transport (GO:0015884),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,PDPN
fructose metabolic process (GO:0006000),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ALDOA
sequestering of BMP from receptor via BMP binding (GO:0038098),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,FSTL1
skeletal myofibril assembly (GO:0014866),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ACTA1
lens fiber cell development (GO:0070307),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ABI2
lymphatic endothelial cell differentiation (GO:0060836),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,PDPN
mammary gland epithelial cell differentiation (GO:0060644),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ID2
TORC1 signaling (GO:0038202),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,LARP1
vascular associated smooth muscle contraction (GO:0014829),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ACTA2
myeloid leukocyte mediated immunity (GO:0002444),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,PLA2G1B
negative regulation of actin nucleation (GO:0051126),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,GMFB
negative regulation of alpha-beta T cell differentiation (GO:0046639),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,GLI3
negative regulation of B cell apoptotic process (GO:0002903),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,FOXP1
negative regulation of mitochondrial fusion (GO:0010637),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,BNIP3
negative regulation of muscle cell differentiation (GO:0051148),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ID2
negative regulation of neuron projection regeneration (GO:0070571),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,INPP5F
negative regulation of sodium ion transport (GO:0010766),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,NEDD4
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ABI2
positive regulation of astrocyte differentiation (GO:0048711),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ID2
positive regulation of extracellular matrix disassembly (GO:0090091),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,PDPN
positive regulation of fibroblast migration (GO:0010763),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,THBS1
positive regulation of leukocyte differentiation (GO:1902107),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,LGALS1
positive regulation of membrane invagination (GO:1905155),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,RAB31
positive regulation of muscle contraction (GO:0045933),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,ENO1
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,CALM1
progesterone receptor signaling pathway (GO:0050847),08-Jan,0.076895119,0.275851122,0,0,14.28138528,36.63622152,NEDD4
positive regulation of protein kinase B signaling (GO:0051897),4/161,0.07733199,0.276835529,0,0,2.566585007,6.569553056,LIN28A;LRP2;F3;THBS1
organic acid transport (GO:0015849),3/100,0.077996113,0.278196901,0,0,3.109194193,7.931853765,SLC7A7;PDPN;SLC38A2
positive regulation of cell-cell adhesion (GO:0022409),2/47,0.079583813,0.278196901,0,0,4.457078398,11.28061834,AFDN;PLAUR
epithelial cell differentiation (GO:0030855),3/101,0.07982136,0.278196901,0,0,3.077311537,7.77933322,TAGLN;PGK1;FSTL1
heart development (GO:0007507),4/164,0.081484101,0.278196901,0,0,2.518076923,6.313693514,ID2;PKP2;GPC3;PDLIM7
intrinsic apoptotic signaling pathway (GO:0097193),3/102,0.081665139,0.278196901,0,0,3.046072975,7.630802882,BNIP3;SFN;PDK1
positive regulation of cellular protein metabolic process (GO:0032270),3/102,0.081665139,0.278196901,0,0,3.046072975,7.630802882,PERP;THBS1;CLN6
positive regulation of vasculature development (GO:1904018),3/102,0.081665139,0.278196901,0,0,3.046072975,7.630802882,ANXA3;F3;THBS1
regulation of protein metabolic process (GO:0051246),2/48,0.082518614,0.278196901,0,0,4.359964688,10.87694077,ODC1;PLAUR
Golgi to plasma membrane transport (GO:0006893),2/48,0.082518614,0.278196901,0,0,4.359964688,10.87694077,RAB31;STEAP2
substrate adhesion-dependent cell spreading (GO:0034446),2/48,0.082518614,0.278196901,0,0,4.359964688,10.87694077,LAMB1;PARVA
myelination (GO:0042552),2/48,0.082518614,0.278196901,0,0,4.359964688,10.87694077,PMP22;MAL2
positive regulation of blood vessel endothelial cell migration (GO:0043536),2/48,0.082518614,0.278196901,0,0,4.359964688,10.87694077,TMSB4X;THBS1
regulation of insulin secretion (GO:0050796),3/104,0.085407567,0.278196901,0,0,2.985451606,7.345168021,GLUD1;SLC2A1;ACSL4
receptor internalization (GO:0031623),2/49,0.085486263,0.278196901,0,0,4.266983476,10.49421737,RAB31;NEDD4
cellular response to mechanical stimulus (GO:0071260),2/49,0.085486263,0.278196901,0,0,4.266983476,10.49421737,CNN2;BNIP3
secondary alcohol metabolic process (GO:1902652),2/49,0.085486263,0.278196901,0,0,4.266983476,10.49421737,SOAT1;CLN6
basement membrane assembly (GO:0070831),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,LAMB1
bundle of His cell to Purkinje myocyte communication (GO:0086069),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,PKP2
regulation of dendritic cell antigen processing and presentation (GO:0002604),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,THBS1
regulation of PERK-mediated unfolded protein response (GO:1903897),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,HSPA5
regulation of pinocytosis (GO:0048548),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,CDC42
embryonic digestive tract morphogenesis (GO:0048557),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,ID2
regulation of protein deacetylation (GO:0090311),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,SPRED1
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,TMSB4X
regulation of transmembrane transporter activity (GO:0022898),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,ACTB
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,FOXP1
regulation of vesicle fusion (GO:0031338),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,ANXA2
response to leptin (GO:0044321),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,LRP2
response to magnesium ion (GO:0032026),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,THBS1
response to misfolded protein (GO:0051788),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,CLU
response to UV-C (GO:0010225),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,IMPACT
sensory organ morphogenesis (GO:0090596),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,GLI3
ketone biosynthetic process (GO:0042181),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,TPI1
skeletal muscle fiber development (GO:0048741),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,ACTA1
lysosomal lumen acidification (GO:0007042),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,CLN6
mitochondrial fragmentation involved in apoptotic process (GO:0043653),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,BNIP3
negative regulation of alpha-beta T cell activation (GO:0046636),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,GLI3
negative regulation of fibrinolysis (GO:0051918),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,THBS1
negative regulation of leukocyte proliferation (GO:0070664),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,ENPP3
negative regulation of membrane potential (GO:0045837),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,BNIP3
negative regulation of protein activation cascade (GO:2000258),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,F3
nucleoside diphosphate catabolic process (GO:0009134),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,NUDT5
ornithine metabolic process (GO:0006591),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,ODC1
plasminogen activation (GO:0031639),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,PGK1
positive regulation of blood pressure (GO:0045777),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,ID2
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,AFDN
positive regulation of ligase activity (GO:0051351),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,TMSB4X
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,BNIP3
"positive regulation of phagocytosis, engulfment (GO:0060100)",09-Jan,0.086083671,0.278196901,0,0,12.49558081,30.64460639,RAB31
positive regulation of cellular metabolic process (GO:0031325),3/105,0.087305846,0.278196901,0,0,2.956032413,7.207805714,INPP5F;ANXA2;THBS1
cellular protein modification process (GO:0006464),15/1025,0.087545467,0.278196901,0,0,1.516707921,3.694089259,GMFB;FEM1B;BRAF;LAMB1;FSTL1;YWHAZ;THBS1;PTPN14;PTPRF;DUSP6;HSP90B1;LGALS1;GPC3;PDK1;CUL4B
actin polymerization or depolymerization (GO:0008154),2/50,0.088485825,0.278196901,0,0,4.177876481,10.1309866,ABI2;DSTN
positive regulation of ion transport (GO:0043270),2/50,0.088485825,0.278196901,0,0,4.177876481,10.1309866,FHL1;PKP2
cellular response to peptide hormone stimulus (GO:0071375),3/106,0.089221922,0.278196901,0,0,2.927184466,7.073917442,RAB31;PKM;PLA2G1B
protein localization to nucleus (GO:0034504),3/106,0.089221922,0.278196901,0,0,2.927184466,7.073917442,POM121;GBP2;IPO5
regulation of interleukin-12 production (GO:0032655),2/51,0.091516379,0.278196901,0,0,4.092406506,9.785915163,THBS1;FOXP1
cholesterol transport (GO:0030301),2/51,0.091516379,0.278196901,0,0,4.092406506,9.785915163,SOAT1;CLU
regulation of smoothened signaling pathway (GO:0008589),2/51,0.091516379,0.278196901,0,0,4.092406506,9.785915163,GPC3;GLI3
gonad development (GO:0008406),2/51,0.091516379,0.278196901,0,0,4.092406506,9.785915163,LRP2;UTF1
positive regulation of fat cell differentiation (GO:0045600),2/51,0.091516379,0.278196901,0,0,4.092406506,9.785915163,NOCT;ID2
neuron projection development (GO:0031175),4/171,0.091590788,0.278196901,0,0,2.41166897,5.764912776,CDC42;NEDD4;STMN2;LAMB1
adherens junction assembly (GO:0034333),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,ACTB
amino sugar metabolic process (GO:0006040),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,GFPT2
regulation of actin filament-based movement (GO:1903115),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,PDPN
apical protein localization (GO:0045176),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,ACTB
arachidonate transport (GO:1903963),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,PLA2G1B
arachidonic acid secretion (GO:0050482),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,PLA2G1B
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,CDC42
regulation of DNA damage checkpoint (GO:2000001),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,FEM1B
regulation of DNA methylation (GO:0044030),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,DNMT3L
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,HSPA5
cellular response to acidic pH (GO:0071468),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,IMPACT
cellular response to leucine starvation (GO:1990253),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,IMPACT
regulation of high voltage-gated calcium channel activity (GO:1901841),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,CALM1
regulation of low-density lipoprotein particle clearance (GO:0010988),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,ANXA2
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,RPS6KA6
regulation of organ growth (GO:0046620),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,DUSP6
"regulation of phagocytosis, engulfment (GO:0060099)",10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,RAB31
endothelium development (GO:0003158),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,FSTL1
regulation of receptor binding (GO:1900120),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,PTPRF
regulation of tau-protein kinase activity (GO:1902947),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,CLU
retinoic acid receptor signaling pathway (GO:0048384),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,ACTN4
sequestering of actin monomers (GO:0042989),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,TMSB4X
serine family amino acid catabolic process (GO:0009071),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,GLDC
iron ion transmembrane transport (GO:0034755),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,SLC40A1
L-glutamate transmembrane transport (GO:0015813),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,SLC1A3
long-chain fatty acid import into cell (GO:0044539),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,SLC2A1
monocyte activation (GO:0042117),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,FOXP1
myelin assembly (GO:0032288),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,PMP22
myelin maintenance (GO:0043217),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,CLU
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,EPCAM
negative regulation of cellular protein catabolic process (GO:1903363),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,ANXA2
negative regulation of hormone secretion (GO:0046888),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,GJA1
negative regulation of lymphocyte apoptotic process (GO:0070229),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,FOXP1
negative regulation of protein autophosphorylation (GO:0031953),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,IMPACT
negative regulation of receptor binding (GO:1900121),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,PTPRF
negative regulation of sodium ion transmembrane transport (GO:1902306),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,NEDD4
negative regulation of sodium ion transmembrane transporter activity (GO:2000650),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,NEDD4
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,IMPACT
negative regulation of transmembrane transport (GO:0034763),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,THBS1
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,INPP5F
negative regulation of voltage-gated calcium channel activity (GO:1901386),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,CALM1
positive regulation by symbiont of entry into host (GO:0075294),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,LGALS1
positive regulation of coagulation (GO:0050820),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,THBS1
positive regulation of epidermis development (GO:0045684),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,SFN
positive regulation of hemostasis (GO:1900048),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,THBS1
positive regulation of viral entry into host cell (GO:0046598),10-Jan,0.095181217,0.278196901,0,0,11.10662177,26.12247076,LGALS1
positive regulation of intracellular signal transduction (GO:1902533),9/546,0.096031978,0.280202894,0,0,1.699264922,3.981503527,GJA1;LGALS1;LIN28A;NEDD4;FLNA;ACTN4;LRP2;F3;THBS1
response to endoplasmic reticulum stress (GO:0034976),3/110,0.097060387,0.282719485,0,0,2.817184818,6.570863708,HSPA5;THBS1;HSP90B1
bicellular tight junction assembly (GO:0070830),2/53,0.097666851,0.283516719,0,0,3.931521847,9.145478888,CLDN6;AFDN
positive regulation of macroautophagy (GO:0016239),2/53,0.097666851,0.283516719,0,0,3.931521847,9.145478888,LARP1;BNIP3
regulation of focal adhesion assembly (GO:0051893),2/54,0.100785001,0.284321763,0,0,3.855720422,8.847975091,THBS1;S100A10
glycosaminoglycan metabolic process (GO:0030203),2/54,0.100785001,0.284321763,0,0,3.855720422,8.847975091,GPC3;CLN6
striated muscle contraction (GO:0006941),2/54,0.100785001,0.284321763,0,0,3.855720422,8.847975091,TPM1;ALDOA
regulation of macroautophagy (GO:0016241),3/112,0.101081428,0.284321763,0,0,2.765212507,6.337393865,LARP1;BNIP3;NEDD4
positive regulation of cell population proliferation (GO:0008284),8/474,0.101876831,0.284321763,0,0,1.737860369,3.969256983,GJA1;EPCAM;PLA2G1B;ID2;S100A6;LAMB1;THBS1;FOXP1
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),6/321,0.102022949,0.284321763,0,0,1.923118678,4.389628969,HSPA5;FEM1B;EDEM1;NEDD4;HSP90B1;CUL4B
regulation of blood vessel endothelial cell migration (GO:0043535),2/55,0.103930607,0.284321763,0,0,3.782779427,8.56433308,TMSB4X;THBS1
actin filament depolymerization (GO:0030042),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,DSTN
aminoglycan metabolic process (GO:0006022),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,CLN6
regulation of amyloid precursor protein biosynthetic process (GO:0042984),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,SOAT1
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,PLAUR
regulation of endocytic recycling (GO:2001135),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,INPP5F
central nervous system myelination (GO:0022010),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,CLU
regulation of lamellipodium morphogenesis (GO:2000392),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,PDPN
copper ion transport (GO:0006825),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,STEAP2
regulation of mast cell activation involved in immune response (GO:0033006),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,ENPP3
regulation of mitochondrial fusion (GO:0010635),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,BNIP3
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,RPS6KA6
establishment of endothelial intestinal barrier (GO:0090557),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,AFDN
establishment of epithelial cell apical/basal polarity (GO:0045198),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,CDC42
regulation of synapse maturation (GO:0090128),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,YWHAZ
glycerol metabolic process (GO:0006071),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,TPI1
Golgi inheritance (GO:0048313),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,YWHAZ
tetrahydrobiopterin metabolic process (GO:0046146),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,CALM1
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,GFPT2
vasoconstriction (GO:0042310),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,ACTA2
monocyte differentiation (GO:0030224),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,MYH9
myotube cell development (GO:0014904),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,ACTA1
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,STRN3
negative regulation of sprouting angiogenesis (GO:1903671),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,THBS1
PERK-mediated unfolded protein response (GO:0036499),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,HSPA5
positive regulation of actin nucleation (GO:0051127),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,ABI2
positive regulation of macrophage differentiation (GO:0045651),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,ID2
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,LIN28A
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,HSPA5
positive regulation of transforming growth factor beta production (GO:0071636),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,THBS1
positive regulation of vacuole organization (GO:0044090),11-Jan,0.104188652,0.284321763,0,0,9.995454545,22.60524081,ANXA2
cellular response to oxygen-containing compound (GO:1901701),6/323,0.104284684,0.284321763,0,0,1.910789297,4.319589081,IMPACT;TPM1;CAPN2;ACTB;IPO5;HSP90B1
response to lipid (GO:0033993),3/114,0.105168261,0.285361014,0,0,2.715113072,6.114960621,NOCT;FOXP1;STRN3
negative regulation of cell motility (GO:2000146),3/114,0.105168261,0.285361014,0,0,2.715113072,6.114960621,AFDN;TPM1;ARID2
positive regulation of cellular component organization (GO:0051130),3/114,0.105168261,0.285361014,0,0,2.715113072,6.114960621,BNIP3;GPC3;CLU
tight junction assembly (GO:0120192),2/56,0.10710282,0.289178149,0,0,3.712539951,8.293687931,CLDN6;AFDN
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),2/56,0.10710282,0.289178149,0,0,3.712539951,8.293687931,SFN;YWHAZ
positive regulation of protein metabolic process (GO:0051247),3/115,0.107235857,0.289178149,0,0,2.690734329,6.007668728,NEDD4;GPC3;CLU
positive regulation of proteolysis (GO:0045862),2/57,0.110300805,0.289178149,0,0,3.644854638,8.035242612,PERP;CLN6
actin crosslink formation (GO:0051764),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,FLNA
purine nucleotide biosynthetic process (GO:0006164),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,PRPS2
amino sugar biosynthetic process (GO:0046349),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,GFPT2
pyrimidine nucleobase metabolic process (GO:0006206),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,DPYSL2
pyrimidine-containing compound metabolic process (GO:0072527),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,ENPP3
regulation of astrocyte differentiation (GO:0048710),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,ID2
regulation of axon regeneration (GO:0048679),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,INPP5F
regulation of B cell apoptotic process (GO:0002902),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,FOXP1
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,CALM1
carnitine metabolic process (GO:0009437),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,ALDH9A1
regulation of dendritic cell differentiation (GO:2001198),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,LGALS1
regulation of histone H3-K9 methylation (GO:0051570),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,DNMT3B
regulation of muscle system process (GO:0090257),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,TPM1
dosage compensation by inactivation of X chromosome (GO:0009048),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,RLIM
regulation of pseudopodium assembly (GO:0031272),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,CDC42
regulation of vascular associated smooth muscle cell migration (GO:1904752),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,TPM1
regulation of ventricular cardiac muscle cell action potential (GO:0098911),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,PKP2
glycine metabolic process (GO:0006544),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,GLDC
histone H3-K9 demethylation (GO:0033169),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,JMJD1C
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,PDK1
maintenance of protein localization in endoplasmic reticulum (GO:0035437),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,HSPA5
tricarboxylic acid metabolic process (GO:0072350),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,GLUD1
very-low-density lipoprotein particle assembly (GO:0034379),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,SOAT1
morphogenesis of a polarized epithelium (GO:0001738),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,ACTB
negative regulation of cell division (GO:0051782),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,TXNIP
negative regulation of microtubule polymerization (GO:0031115),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,STMN2
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,CALM1
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,CALM1
neurotransmitter uptake (GO:0001504),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,SLC1A3
nucleotide-sugar metabolic process (GO:0009225),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,GFPT2
positive regulation of protein depolymerization (GO:1901881),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,STMN2
positive regulation of pseudopodium assembly (GO:0031274),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,CDC42
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),12-Jan,0.113106866,0.289178149,0,0,9.086317723,19.8029225,HSPA5
receptor metabolic process (GO:0043112),2/58,0.113523744,0.289178149,0,0,3.579586657,7.788261576,RAB31;NEDD4
muscle organ development (GO:0007517),2/58,0.113523744,0.289178149,0,0,3.579586657,7.788261576,TAGLN;FHL1
positive regulation of mitochondrion organization (GO:0010822),2/58,0.113523744,0.289178149,0,0,3.579586657,7.788261576,BNIP3;PLAUR
regulation of cellular response to stress (GO:0080135),3/118,0.113532971,0.289178149,0,0,2.62014197,5.700543302,POM121;SLC38A2;CRYAB
apical junction assembly (GO:0043297),2/60,0.120041265,0.296828855,0,0,3.455802556,7.326023983,CLDN6;AFDN
cellular protein catabolic process (GO:0044257),2/60,0.120041265,0.296828855,0,0,3.455802556,7.326023983,BNIP3;CAPN2
response to organic cyclic compound (GO:0014070),2/60,0.120041265,0.296828855,0,0,3.455802556,7.326023983,GLDC;STRN3
pteridine-containing compound metabolic process (GO:0042558),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,CALM1
purine-containing compound salvage (GO:0043101),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,ADK
regulation of actomyosin structure organization (GO:0110020),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,CDC42
atrial cardiac muscle cell action potential (GO:0086014),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,GJA1
regulation of cell communication by electrical coupling (GO:0010649),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,CALM1
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,FOXP1
cellular biogenic amine metabolic process (GO:0006576),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,ODC1
regulation of fibrinolysis (GO:0051917),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,THBS1
regulation of homotypic cell-cell adhesion (GO:0034110),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,PLAUR
regulation of lysosomal lumen pH (GO:0035751),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,CLN6
cytoplasmic sequestering of protein (GO:0051220),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,FLNA
detection of calcium ion (GO:0005513),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,CALM1
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,F3
entry into host (GO:0044409),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,CTNND1
regulation of response to stress (GO:0080134),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,SLC38A2
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,EDEM1
icosanoid secretion (GO:0032309),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,PLA2G1B
transport along microtubule (GO:0010970),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,CDC42
mitochondrial outer membrane permeabilization (GO:0097345),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,BNIP3
UDP-N-acetylglucosamine metabolic process (GO:0006047),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,GFPT2
UV-damage excision repair (GO:0070914),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,CUL4B
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,HSPA5
negative regulation of histone methylation (GO:0031061),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,DNMT3B
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,NEDD4
plasma membrane repair (GO:0001778),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,MYH9
polyamine metabolic process (GO:0006595),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,ODC1
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,EDEM1
positive regulation of sodium ion transport (GO:0010765),13-Jan,0.121936736,0.296828855,0,0,8.328703704,17.52569911,PKP2
positive regulation of interleukin-8 production (GO:0032757),2/61,0.123334275,0.299185693,0,0,3.397057558,7.109555437,PLA2G1B;F3
negative regulation of cell differentiation (GO:0045596),4/191,0.123517773,0.299185693,0,0,2.151542575,4.499672066,SPRED1;ID2;NOCT;PKP2
regulation of tumor necrosis factor production (GO:0032680),3/124,0.126533552,0.299185693,0,0,2.489458593,5.146327725,CLU;THBS1;FOXP1
negative regulation of kinase activity (GO:0033673),2/62,0.126649091,0.299185693,0,0,3.340270728,6.902118576,SPRED1;SFN
negative regulation of signal transduction (GO:0009968),5/267,0.128398191,0.299185693,0,0,1.922070512,3.94527841,NEDD4;SPRY4;GPC3;THBS1;GLI3
negative regulation of macromolecule metabolic process (GO:0010605),4/194,0.128671151,0.299185693,0,0,2.117246964,4.341405046,SFMBT2;ID2;NOCT;FOXP1
regulation of protein secretion (GO:0050708),3/125,0.128750626,0.299185693,0,0,2.468927735,5.061000347,PLA2G1B;SLC2A1;MYH10
central nervous system development (GO:0007417),5/268,0.129851503,0.299185693,0,0,1.914664262,3.908526248,RPS6KA6;MARCKS;ADAM23;SLC2A1;ADGRL2
cellular response to reactive oxygen species (GO:0034614),2/63,0.129984959,0.299185693,0,0,3.28534576,6.703210983,IMPACT;TPM1
activation of cysteine-type endopeptidase activity (GO:0097202),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,PERP
branching involved in blood vessel morphogenesis (GO:0001569),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,SEMA3E
regulation of integrin-mediated signaling pathway (GO:2001044),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,FLNA
regulation of IRE1-mediated unfolded protein response (GO:1903894),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,HSPA5
defense response to protozoan (GO:0042832),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,GBP2
dicarboxylic acid catabolic process (GO:0043649),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,GLUD1
endothelial cell differentiation (GO:0045446),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,FSTL1
regulation of response to endoplasmic reticulum stress (GO:1905897),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,CLU
regulation of trophoblast cell migration (GO:1901163),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,GJA1
respiratory electron transport chain (GO:0022904),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,GPD2
ribonucleoside monophosphate biosynthetic process (GO:0009156),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,ADK
sequestering of extracellular ligand from receptor (GO:0035581),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,FSTL1
smooth muscle contraction (GO:0006939),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,ACTA2
synaptic membrane adhesion (GO:0099560),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,PTPRF
T cell differentiation in thymus (GO:0033077),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,GLI3
T-helper cell differentiation (GO:0042093),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,FOXP1
ncRNA transcription (GO:0098781),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,CAVIN1
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,THBS1
negative regulation of interleukin-12 production (GO:0032695),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,THBS1
negative regulation of smooth muscle cell migration (GO:0014912),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,TPM1
negative regulation of T cell differentiation (GO:0045581),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,GLI3
negative regulation of translational initiation (GO:0045947),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,LARP1
neuron fate commitment (GO:0048663),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,ID2
neurotransmitter biosynthetic process (GO:0042136),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,ALDH9A1
nucleoside phosphate catabolic process (GO:1901292),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,ENPP3
nucleoside triphosphate metabolic process (GO:0009141),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,ENPP3
polarized epithelial cell differentiation (GO:0030859),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,CDC42
positive regulation of alpha-beta T cell differentiation (GO:0046638),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,GLI3
positive regulation of glycoprotein biosynthetic process (GO:0010560),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,SOAT1
positive regulation of macrophage chemotaxis (GO:0010759),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,THBS1
positive regulation of protein-containing complex disassembly (GO:0043243),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,BNIP3
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,ACTN4
positive regulation of transmembrane transport (GO:0034764),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,BRAF
pre-miRNA processing (GO:0031054),14-Jan,0.130679135,0.299185693,0,0,7.687645688,15.64443825,LIN28A
circulatory system development (GO:0072359),3/126,0.13098153,0.299185693,0,0,2.448730712,4.977532368,ID2;PKP2;PDLIM7
negative regulation of cell growth (GO:0030308),3/126,0.13098153,0.299185693,0,0,2.448730712,4.977532368,GJA1;FHL1;ENO1
negative regulation of growth (GO:0045926),3/126,0.13098153,0.299185693,0,0,2.448730712,4.977532368,GJA1;FHL1;ENO1
regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/64,0.133341138,0.303355539,0,0,3.232192566,6.512365381,FEM1B;THBS1
diterpenoid metabolic process (GO:0016101),2/64,0.133341138,0.303355539,0,0,3.232192566,6.512365381,GPC3;LRP2
protein catabolic process (GO:0030163),2/64,0.133341138,0.303355539,0,0,3.232192566,6.512365381,CLN6;CUL4B
negative regulation of intracellular signal transduction (GO:1902532),4/198,0.135679953,0.30517572,0,0,2.073169442,4.141065686,SPRED1;TMSB4X;PLAUR;THBS1
regulation of cell-matrix adhesion (GO:0001952),2/65,0.136716898,0.30517572,0,0,3.180726775,6.32914668,SEMA3E;THBS1
cellular response to insulin stimulus (GO:0032869),3/129,0.137755179,0.30517572,0,0,2.390063168,4.737767799,RAB31;PKM;PLA2G1B
cellular response to ATP (GO:0071318),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,HSP90B1
regulation of extracellular matrix disassembly (GO:0010715),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,PDPN
contractile actin filament bundle assembly (GO:0030038),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,ZYX
regulation of macrophage differentiation (GO:0045649),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,ID2
regulation of non-canonical Wnt signaling pathway (GO:2000050),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,GPC3
endoplasmic reticulum to cytosol transport (GO:1903513),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,HSP90B1
engulfment of apoptotic cell (GO:0043652),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,THBS1
establishment of apical/basal cell polarity (GO:0035089),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,CDC42
fibrinolysis (GO:0042730),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,PLAUR
glucan catabolic process (GO:0009251),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,CALM1
glycogen catabolic process (GO:0005980),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,CALM1
response to acidic pH (GO:0010447),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,IMPACT
icosanoid biosynthetic process (GO:0046456),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,PLA2G1B
stress fiber assembly (GO:0043149),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,ZYX
macrophage differentiation (GO:0030225),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,CDC42
mammary gland epithelium development (GO:0061180),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,ID2
vitamin D metabolic process (GO:0042359),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,LRP2
negative regulation of androgen receptor signaling pathway (GO:0060766),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,FOXP1
negative regulation of protein processing (GO:0010955),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,THBS1
nucleobase-containing small molecule catabolic process (GO:0034656),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,NUDT5
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,SPRED1
positive regulation of double-strand break repair via homologous recombination (GO:1905168),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,ARID2
positive regulation of endothelial cell chemotaxis (GO:2001028),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,TMSB4X
positive regulation of histone H3-K4 methylation (GO:0051571),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,DNMT3B
positive regulation of sprouting angiogenesis (GO:1903672),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,PKM
protein localization to cell-cell junction (GO:0150105),15-Jan,0.139334924,0.30517572,0,0,7.138167388,14.06843366,ACTB
regulation of response to external stimulus (GO:0032101),3/130,0.140039359,0.306089791,0,0,2.371123252,4.661229393,TMSB4X;CALM1;FOXP1
positive regulation of cell death (GO:0010942),2/66,0.140111524,0.306089791,0,0,3.130869289,6.153149305,BNIP3;CLU
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/67,0.143524311,0.312692363,0,0,3.082545881,5.983994791,CDC42;PLAUR
positive regulation of catabolic process (GO:0009896),2/67,0.143524311,0.312692363,0,0,3.082545881,5.983994791,NEDD4;GPC3
regulation of translational initiation (GO:0006446),2/68,0.146954567,0.312692363,0,0,3.035686817,5.8213296,IMPACT;LARP1
positive regulation of protein localization to nucleus (GO:1900182),2/68,0.146954567,0.312692363,0,0,3.035686817,5.8213296,FLNA;IPO5
regulation of amyloid-beta clearance (GO:1900221),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,CLU
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,THBS1
basement membrane organization (GO:0071711),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,LAMB1
regulation of cellular carbohydrate metabolic process (GO:0010675),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,PDK1
cellular polysaccharide catabolic process (GO:0044247),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,CALM1
regulation of interleukin-1 production (GO:0032652),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,FOXP1
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,CLU
dendrite self-avoidance (GO:0070593),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,EMB
dendritic spine morphogenesis (GO:0060997),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,CDC42
regulation of monocyte differentiation (GO:0045655),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,FOXP1
digestive tract morphogenesis (GO:0048546),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,ID2
male meiosis I (GO:0007141),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,DNMT3L
transepithelial transport (GO:0070633),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,SLC1A3
negative regulation of cell-substrate junction organization (GO:0150118),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,THBS1
negative regulation of epithelial cell differentiation (GO:0030857),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,SPRED1
negative regulation of focal adhesion assembly (GO:0051895),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,THBS1
negative regulation of immune effector process (GO:0002698),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,ENPP3
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,INPP5F
negative regulation of release of cytochrome c from mitochondria (GO:0090201),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,CLU
negative regulation of transcription regulatory region DNA binding (GO:2000678),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,TMSB4X
positive regulation of endothelial cell apoptotic process (GO:2000353),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,THBS1
protein localization to endoplasmic reticulum (GO:0070972),16-Jan,0.147904956,0.312692363,0,0,6.661952862,12.73222705,HSPA5
proteasomal protein catabolic process (GO:0010498),4/205,0.148308246,0.313156445,0,0,2.000255135,3.817411773,FEM1B;NEDD4;ENC1;CUL4B
cellular response to decreased oxygen levels (GO:0036294),2/69,0.150401612,0.316791528,0,0,2.990226532,5.664823147,BNIP3;PGK1
positive regulation of protein transport (GO:0051222),2/69,0.150401612,0.316791528,0,0,2.990226532,5.664823147,PLA2G1B;MYH10
regulation of protein kinase B signaling (GO:0051896),4/207,0.151997691,0.319758107,0,0,1.980346091,3.73075409,LIN28A;LRP2;F3;THBS1
defense response to Gram-positive bacterium (GO:0050830),2/70,0.153864776,0.320684346,0,0,2.946103314,5.514166007,PLA2G1B;GBP2
establishment of protein localization to membrane (GO:0090150),2/70,0.153864776,0.320684346,0,0,2.946103314,5.514166007,AFDN;BRAF
sterol metabolic process (GO:0016125),2/70,0.153864776,0.320684346,0,0,2.946103314,5.514166007,SOAT1;CLN6
wound healing (GO:0042060),2/70,0.153864776,0.320684346,0,0,2.946103314,5.514166007,TPM1;MYH9
pyrimidine-containing compound catabolic process (GO:0072529),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,DPYSL2
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,CALM1
regulation of cellular response to growth factor stimulus (GO:0090287),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,FSTL1
cellular response to gamma radiation (GO:0071480),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,CRYAB
epithelial cell morphogenesis (GO:0003382),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,COL18A1
establishment of protein localization to endoplasmic reticulum (GO:0072599),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,EDEM1
regulation of transferase activity (GO:0051338),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,FEM1B
histone H2A monoubiquitination (GO:0035518),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,CUL4B
histone H2A ubiquitination (GO:0033522),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,CUL4B
"retrograde protein transport, ER to cytosol (GO:0030970)",17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,HSP90B1
reverse cholesterol transport (GO:0043691),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,CLU
modified amino acid transport (GO:0072337),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,PDPN
negative regulation of amyloid-beta formation (GO:1902430),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,CLU
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,TPM1
positive regulation of heart rate (GO:0010460),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,TPM1
positive regulation of macrophage activation (GO:0043032),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,THBS1
positive regulation of positive chemotaxis (GO:0050927),17-Jan,0.156390077,0.320684346,0,0,6.245265152,11.58747681,F3
regulation of G1/S transition of mitotic cell cycle (GO:2000045),2/71,0.157343404,0.321864537,0,0,2.90325903,5.369068283,ID2;FHL1
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),2/71,0.157343404,0.321864537,0,0,2.90325903,5.369068283,CDC42;ACTB
nervous system development (GO:0007399),7/447,0.159083643,0.323507001,0,0,1.604249527,2.94913226,RPS6KA6;MARCKS;GMFB;DPYSL2;ADAM23;SLC2A1;PMP22
Fc-gamma receptor signaling pathway (GO:0038094),2/72,0.160836848,0.323507001,0,0,2.861638869,5.229258126,CDC42;ACTB
positive regulation of secretion by cell (GO:1903532),2/72,0.160836848,0.323507001,0,0,2.861638869,5.229258126,PLA2G1B;MYH10
protein dephosphorylation (GO:0006470),3/139,0.161148735,0.323507001,0,0,2.213197779,4.04003214,PTPN14;PTPRF;DUSP6
protein localization to cell periphery (GO:1990778),3/140,0.163551784,0.323507001,0,0,2.196931327,3.977820136,PKP2;FLNA;S100A10
regulation of actin filament-based process (GO:0032970),2/73,0.164344474,0.323507001,0,0,2.821191106,5.094480381,CNN2;RHOBTB3
response to molecule of bacterial origin (GO:0002237),2/73,0.164344474,0.323507001,0,0,2.821191106,5.094480381,NOCT;FOXP1
regulation of B cell differentiation (GO:0045577),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,ID2
regulation of catabolic process (GO:0009894),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,ODC1
cellular response to pH (GO:0071467),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,IMPACT
chromatin disassembly (GO:0031498),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,ARID2
regulation of membrane depolarization (GO:0003254),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,FHL1
regulation of platelet aggregation (GO:0090330),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PDPN
embryonic digit morphogenesis (GO:0042733),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,GLI3
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,LIN28A
regulation of protein-containing complex disassembly (GO:0043244),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,BNIP3
fluid transport (GO:0042044),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PDPN
regulation of transcription by RNA polymerase I (GO:0006356),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,FLNA
glycoprotein catabolic process (GO:0006516),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,EDEM1
rRNA transcription (GO:0009303),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,CAVIN1
intermediate filament organization (GO:0045109),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PKP2
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,ACSL4
microtubule depolymerization (GO:0007019),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,STMN2
ventricular cardiac muscle cell action potential (GO:0086005),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PKP2
water transport (GO:0006833),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PDPN
negative regulation of interleukin-8 production (GO:0032717),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,TMSB4X
nucleosome disassembly (GO:0006337),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,ARID2
nucleotide biosynthetic process (GO:0009165),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PRPS2
phosphatidylglycerol acyl-chain remodeling (GO:0036148),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PLA2G1B
phosphatidylinositol acyl-chain remodeling (GO:0036149),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PLA2G1B
positive regulation of amyloid-beta formation (GO:1902004),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,CLU
positive regulation of extracellular matrix organization (GO:1903055),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PDPN
positive regulation of glial cell differentiation (GO:0045687),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,ID2
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,PRDX6
positive regulation of phosphoprotein phosphatase activity (GO:0032516),18-Jan,0.164791125,0.323507001,0,0,5.877599525,10.59776169,CALM1
cytokine-mediated signaling pathway (GO:0019221),9/621,0.167600625,0.326302668,0,0,1.485216718,2.652851569,CNN2;CDC42;ANXA2;TMSB4X;ACTN4;GBP2;F3;YWHAZ;HSP90B1
proteolysis involved in cellular protein catabolic process (GO:0051603),2/74,0.16786566,0.326302668,0,0,2.781866892,4.964495352,CAPN2;CUL4B
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",2/74,0.16786566,0.326302668,0,0,2.781866892,4.964495352,RPS6KA6;SFN
Fc receptor mediated stimulatory signaling pathway (GO:0002431),2/74,0.16786566,0.326302668,0,0,2.781866892,4.964495352,CDC42;ACTB
mitotic nuclear division (GO:0140014),2/74,0.16786566,0.326302668,0,0,2.781866892,4.964495352,STAG2;FLNA
negative regulation of protein binding (GO:0032091),2/74,0.16786566,0.326302668,0,0,2.781866892,4.964495352,ACTB;PTPRF
negative regulation of DNA-binding transcription factor activity (GO:0043433),3/143,0.170824729,0.326302668,0,0,2.149526239,3.798464846,ID2;TMSB4X;FLNA
neuron development (GO:0048666),3/143,0.170824729,0.326302668,0,0,2.149526239,3.798464846,NEDD4;STMN2;LAMB1
regulation of cell growth (GO:0001558),4/217,0.170952554,0.326302668,0,0,1.886409053,3.332094895,CDC42;GJA1;FHL1;ENO1
fibroblast growth factor receptor signaling pathway (GO:0008543),2/75,0.171399791,0.326302668,0,0,2.743620054,4.839077678,SPRED1;ESRP1
response to amino acid starvation (GO:1990928),2/75,0.171399791,0.326302668,0,0,2.743620054,4.839077678,IMPACT;LARP1
Rac protein signal transduction (GO:0016601),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,ABI2
cardiac muscle cell contraction (GO:0086003),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,PKP2
regulation of histone H3-K4 methylation (GO:0051569),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,DNMT3B
regulation of mitochondrial membrane permeability (GO:0046902),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,BNIP3
diol metabolic process (GO:0034311),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,CALM1
establishment of skin barrier (GO:0061436),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,SFN
fatty acid transmembrane transport (GO:1902001),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,SLC2A1
glycerolipid catabolic process (GO:0046503),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,PRDX6
regulation of water loss via skin (GO:0033561),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,SFN
response to ATP (GO:0033198),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,HSP90B1
response to fatty acid (GO:0070542),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,GLDC
leukotriene biosynthetic process (GO:0019370),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,PLA2G1B
maintenance of protein localization in organelle (GO:0072595),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,HSPA5
ureteric bud development (GO:0001657),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,GPC3
vesicle transport along actin filament (GO:0030050),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,ACTN4
myeloid cell activation involved in immune response (GO:0002275),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,ENPP3
negative regulation of amyloid precursor protein catabolic process (GO:1902992),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,CLU
NLS-bearing protein import into nucleus (GO:0006607),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,IPO5
nucleotide-sugar biosynthetic process (GO:0009226),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,GFPT2
pore complex assembly (GO:0046931),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,AFDN
positive regulation of actin cytoskeleton reorganization (GO:2000251),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,CDC42
positive regulation of focal adhesion assembly (GO:0051894),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,S100A10
positive regulation of leukocyte activation (GO:0002696),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,THBS1
positive regulation of macrophage migration (GO:1905523),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,THBS1
positive regulation of mitochondrial fission (GO:0090141),19-Jan,0.173108927,0.326302668,0,0,5.550785634,9.735157942,BNIP3
establishment of protein localization to organelle (GO:0072594),2/76,0.174946267,0.328313259,0,0,2.706406915,4.718015297,POM121;IPO5
regulation of RNA splicing (GO:0043484),2/76,0.174946267,0.328313259,0,0,2.706406915,4.718015297,ESRP1;SLC38A2
water-soluble vitamin metabolic process (GO:0006767),2/76,0.174946267,0.328313259,0,0,2.706406915,4.718015297,SLC2A1;SLC2A3
protein import into nucleus (GO:0006606),2/76,0.174946267,0.328313259,0,0,2.706406915,4.718015297,POM121;IPO5
regulation of mRNA stability (GO:0043488),3/146,0.178189136,0.332269565,0,0,2.104110176,3.629400115,LARP1;NOCT;YWHAZ
cholesterol metabolic process (GO:0008203),2/77,0.178504495,0.332269565,0,0,2.670186125,4.601108507,SOAT1;CLN6
import into nucleus (GO:0051170),2/77,0.178504495,0.332269565,0,0,2.670186125,4.601108507,POM121;IPO5
negative regulation of developmental process (GO:0051093),2/77,0.178504495,0.332269565,0,0,2.670186125,4.601108507,RPS6KA6;BNIP3
positive regulation of tumor necrosis factor production (GO:0032760),2/77,0.178504495,0.332269565,0,0,2.670186125,4.601108507,CLU;THBS1
protein-DNA complex disassembly (GO:0032986),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,ARID2
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,CLDN6
regulation of granulocyte chemotaxis (GO:0071622),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,THBS1
regulation of protein localization to cell periphery (GO:1904375),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,ACTB
energy reserve metabolic process (GO:0006112),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,GFPT2
establishment of epithelial cell polarity (GO:0090162),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,CDC42
ganglioside metabolic process (GO:0001573),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,CLN6
gastrulation (GO:0007369),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,GPC3
mesoderm development (GO:0007498),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,MEST
miRNA metabolic process (GO:0010586),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,LIN28A
xenobiotic transport (GO:0042908),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,GJA1
negative regulation of axon extension involved in axon guidance (GO:0048843),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,SEMA3E
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,IPO5
nucleobase-containing compound biosynthetic process (GO:0034654),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,ADK
positive regulation of alpha-beta T cell activation (GO:0046635),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,GLI3
positive regulation of epidermal cell differentiation (GO:0045606),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,SFN
positive regulation of epithelial cell differentiation (GO:0030858),20-Jan,0.181344305,0.332269565,0,0,5.258373206,8.9779246,SFN
negative regulation of protein serine/threonine kinase activity (GO:0071901),2/78,0.182073896,0.333248033,0,0,2.634918515,4.488169093,SPRY4;IPO5
positive regulation of hydrolase activity (GO:0051345),3/149,0.185639606,0.336359076,0,0,2.060560526,3.469876952,AFDN;CALM1;S100A10
regulation of cellular response to heat (GO:1900034),2/79,0.185653898,0.336359076,0,0,2.600566946,4.379019536,POM121;CRYAB
regulation of neuron differentiation (GO:0045664),2/79,0.185653898,0.336359076,0,0,2.600566946,4.379019536,IMPACT;ID2
negative regulation of NF-kappaB transcription factor activity (GO:0032088),2/79,0.185653898,0.336359076,0,0,2.600566946,4.379019536,TMSB4X;G3BP2
regulation of fat cell differentiation (GO:0045598),2/80,0.18924394,0.336359076,0,0,2.567096186,4.273492279,NOCT;ID2
regulation of NIK/NF-kappaB signaling (GO:1901222),2/80,0.18924394,0.336359076,0,0,2.567096186,4.273492279,TMSB4X;ACTN4
glycerophospholipid metabolic process (GO:0006650),2/80,0.18924394,0.336359076,0,0,2.567096186,4.273492279,PLA2G1B;PRDX6
skin development (GO:0043588),2/80,0.18924394,0.336359076,0,0,2.567096186,4.273492279,TXNIP;SFN
positive regulation of cell adhesion (GO:0045785),2/80,0.18924394,0.336359076,0,0,2.567096186,4.273492279,AFDN;TPM1
actin filament-based transport (GO:0099515),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,ACTN4
purinergic nucleotide receptor signaling pathway (GO:0035590),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,TXNIP
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,CALM1
regulation of fibroblast migration (GO:0010762),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,THBS1
epithelial cell development (GO:0002064),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,ACTA2
response to progesterone (GO:0032570),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,THBS1
innate immune response in mucosa (GO:0002227),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,PLA2G1B
vacuolar acidification (GO:0007035),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,CLN6
negative regulation of ion transmembrane transporter activity (GO:0032413),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,NEDD4
negative regulation of microtubule depolymerization (GO:0007026),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,STMN2
negative regulation of reproductive process (GO:2000242),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,GJA1
negative regulation of response to wounding (GO:1903035),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,INPP5F
negative regulation of small GTPase mediated signal transduction (GO:0051058),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,SPRY4
neuron apoptotic process (GO:0051402),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,BNIP3
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,CUL4B
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,CUL4B
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,FOXP1
positive regulation of immune system process (GO:0002684),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,PLA2G1B
positive regulation of phosphatase activity (GO:0010922),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,CALM1
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),21-Jan,0.189498071,0.336359076,0,0,4.99520202,8.308901318,GJA1
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/81,0.192843473,0.340750036,0,0,2.534472788,4.171429055,BEX3;F3
negative regulation of protein modification process (GO:0031400),2/81,0.192843473,0.340750036,0,0,2.534472788,4.171429055,BEX4;IMPACT
positive regulation of cellular amide metabolic process (GO:0034250),2/81,0.192843473,0.340750036,0,0,2.534472788,4.171429055,CLU;THBS1
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/81,0.192843473,0.340750036,0,0,2.534472788,4.171429055,CLU;THBS1
dephosphorylation (GO:0016311),3/153,0.195698205,0.340750036,0,0,2.005204082,3.270851954,PTPN14;PTPRF;DUSP6
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),2/82,0.196451955,0.340750036,0,0,2.502664975,4.072680267,ACTB;IPO5
ephrin receptor signaling pathway (GO:0048013),2/82,0.196451955,0.340750036,0,0,2.502664975,4.072680267,CDC42;ACTB
amino acid import (GO:0043090),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,SLC1A3
regulation of cardiac muscle cell membrane repolarization (GO:0099623),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,FLNA
cellular response to nerve growth factor stimulus (GO:1990090),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,STMN2
chaperone-mediated protein complex assembly (GO:0051131),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,CLU
regulation of lipid storage (GO:0010883),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,MEST
regulation of macrophage chemotaxis (GO:0010758),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,THBS1
fatty-acyl-CoA metabolic process (GO:0035337),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,ACSL4
limb morphogenesis (GO:0035108),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,GLI3
microglial cell activation (GO:0001774),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,CLU
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,NEDD4
negative regulation of B cell activation (GO:0050869),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,ID2
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,IPO5
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,CUL4B
peptidyl-threonine dephosphorylation (GO:0035970),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,DUSP6
phosphatidylserine acyl-chain remodeling (GO:0036150),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,PLA2G1B
positive regulation of amyloid precursor protein catabolic process (GO:1902993),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,CLU
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,CALM1
positive regulation of neural precursor cell proliferation (GO:2000179),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,LRP2
positive regulation of signal transduction by p53 class mediator (GO:1901798),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,SPRED1
positive regulation of translational initiation (GO:0045948),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,LARP1
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),22-Jan,0.19757103,0.340750036,0,0,4.757094757,7.714376542,ENC1
regulation of defense response (GO:0031347),2/83,0.200068856,0.34436094,0,0,2.471642539,3.977104419,TMSB4X;FOXP1
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),2/83,0.200068856,0.34436094,0,0,2.471642539,3.977104419,CDC42;ABI2
regulation of cytokinesis (GO:0032465),2/84,0.203693654,0.34819187,0,0,2.441376749,3.884567582,CDC42;CALM1
spindle assembly (GO:0051225),2/84,0.203693654,0.34819187,0,0,2.441376749,3.884567582,STAG2;FLNA
regulation of B cell receptor signaling pathway (GO:0050855),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,FOXP1
blood vessel endothelial cell migration (GO:0043534),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,MYH9
regulation of cysteine-type endopeptidase activity (GO:2000116),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,BEX3
cytoskeleton-dependent intracellular transport (GO:0030705),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,TUBA1A
regulation of mononuclear cell migration (GO:0071675),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,THBS1
regulation of neural precursor cell proliferation (GO:2000177),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,ID2
regulation of protein export from nucleus (GO:0046825),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,PTPN14
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,CALM1
regulation of supramolecular fiber organization (GO:1902903),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,MAP1B
membrane protein ectodomain proteolysis (GO:0006509),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,MYH9
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,CUL4B
positive regulation of morphogenesis of an epithelium (GO:1905332),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,GJA1
positive regulation of mRNA processing (GO:0050685),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,PRDX6
positive regulation of protein autophosphorylation (GO:0031954),23-Jan,0.20556398,0.34819187,0,0,4.540633609,7.183273096,CALM1
positive regulation of protein catabolic process (GO:0045732),2/85,0.207325838,0.350827436,0,0,2.411840254,3.794942912,NEDD4;GPC3
purine nucleotide metabolic process (GO:0006163),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,PRPS2
amino acid import across plasma membrane (GO:0089718),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,SLC1A3
regulation of axon extension involved in axon guidance (GO:0048841),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,SEMA3E
axon extension (GO:0048675),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,MAP1B
cholesterol efflux (GO:0033344),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,SOAT1
regulation of monooxygenase activity (GO:0032768),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,CALM1
establishment of mitotic spindle orientation (GO:0000132),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,GJA1
extracellular matrix assembly (GO:0085029),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,LAMB1
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,NEDD4
response to gamma radiation (GO:0010332),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,CRYAB
histone monoubiquitination (GO:0010390),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,CUL4B
leukotriene metabolic process (GO:0006691),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,PLA2G1B
long-chain fatty-acyl-CoA metabolic process (GO:0035336),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,ACSL4
negative regulation of NIK/NF-kappaB signaling (GO:1901223),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,TMSB4X
negative regulation of protein depolymerization (GO:1901880),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,STMN2
phospholipid catabolic process (GO:0009395),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,PRDX6
positive regulation of cell-substrate junction organization (GO:0150117),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,S100A10
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,THBS1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,HSPA5
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,THBS1
positive regulation of viral life cycle (GO:1903902),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,LGALS1
"protein alpha-1,2-demannosylation (GO:0036508)",24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,EDEM1
protein exit from endoplasmic reticulum (GO:0032527),24-Jan,0.213477707,0.353170887,0,0,4.342995169,6.706552451,HSP90B1
receptor catabolic process (GO:0032801),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,NEDD4
cardiac conduction system development (GO:0003161),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,GJA1
regulation of epidermal cell differentiation (GO:0045604),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,SFN
cellular response to hexose stimulus (GO:0071331),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,LIN28A
regulation of mitochondrial fission (GO:0090140),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,BNIP3
energy derivation by oxidation of organic compounds (GO:0015980),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,GFPT2
regulation of rhodopsin mediated signaling pathway (GO:0022400),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,CALM1
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,CALM1
fat-soluble vitamin metabolic process (GO:0006775),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,LRP2
negative regulation of actin filament polymerization (GO:0030837),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,TMSB4X
negative regulation of cell junction assembly (GO:1901889),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,THBS1
negative regulation of ion transport (GO:0043271),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,NEDD4
negative regulation of response to endoplasmic reticulum stress (GO:1903573),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,CLU
peripheral nervous system development (GO:0007422),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,PMP22
phosphatidylglycerol metabolic process (GO:0046471),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,PLA2G1B
phosphatidylinositol dephosphorylation (GO:0046856),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,INPP5F
positive regulation of ERBB signaling pathway (GO:1901186),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,PLAUR
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),25-Jan,0.221312995,0.359844794,0,0,4.161826599,6.276772451,CALM1
transforming growth factor beta receptor signaling pathway (GO:0007179),2/89,0.221918513,0.360142044,0,0,2.300484276,3.4632526,ZYX;CGN
post-Golgi vesicle-mediated transport (GO:0006892),2/89,0.221918513,0.360142044,0,0,2.300484276,3.4632526,STEAP2;AP1M2
protein modification by small protein conjugation (GO:0032446),6/409,0.223526815,0.362406939,0,0,1.496393628,2.241932687,POM121;NEDD4;ENC1;MKRN1;RLIM;CUL4B
negative regulation of protein kinase activity (GO:0006469),2/90,0.225580267,0.365041572,0,0,2.274227042,3.386504256,SPRED1;SFN
positive regulation of autophagy (GO:0010508),2/90,0.225580267,0.365041572,0,0,2.274227042,3.386504256,LARP1;BNIP3
regulation of actin filament bundle assembly (GO:0032231),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,CDC42
chaperone cofactor-dependent protein refolding (GO:0051085),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,HSPA5
clathrin-dependent endocytosis (GO:0072583),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,INPP5F
endothelial cell development (GO:0001885),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,COL18A1
global genome nucleotide-excision repair (GO:0070911),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,CUL4B
hippo signaling (GO:0035329),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,AMOTL2
histone lysine demethylation (GO:0070076),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,JMJD1C
meiosis I (GO:0007127),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,DNMT3L
TOR signaling (GO:0031929),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,LARP1
mononuclear cell differentiation (GO:1903131),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,MYH9
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,CLU
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,PLA2G1B
positive regulation of filopodium assembly (GO:0051491),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,CDC42
positive regulation of histone methylation (GO:0031062),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,DNMT3B
positive regulation of microtubule polymerization or depolymerization (GO:0031112),26-Jan,0.229070617,0.365080449,0,0,3.995151515,5.887754478,STMN2
regulation of actin cytoskeleton organization (GO:0032956),2/91,0.229246526,0.365080449,0,0,2.248559859,3.312032708,RHOBTB3;SEMA3E
positive regulation of supramolecular fiber organization (GO:1902905),2/91,0.229246526,0.365080449,0,0,2.248559859,3.312032708,STMN2;CLU
positive regulation of DNA-binding transcription factor activity (GO:0051091),4/246,0.229973361,0.365895991,0,0,1.657893622,2.436758449,BEX1;ANXA3;PLA2G1B;CLU
regulation of cell population proliferation (GO:0042127),10/764,0.231287711,0.367643899,0,0,1.336575302,1.956870331,BEX4;COL18A1;EPCAM;PLA2G1B;ID2;PDPN;ARID2;CLU;THBS1;PTPN14
regulation of endothelial cell proliferation (GO:0001936),2/92,0.23291684,0.369200275,0,0,2.223463057,3.239749762,F3;THBS1
cellular response to fibroblast growth factor stimulus (GO:0044344),2/92,0.23291684,0.369200275,0,0,2.223463057,3.239749762,SPRED1;ESRP1
retinoid metabolic process (GO:0001523),2/92,0.23291684,0.369200275,0,0,2.223463057,3.239749762,GPC3;LRP2
regulation of heart contraction (GO:0008016),2/93,0.236590769,0.370114018,0,0,2.198917833,3.169571498,TPM1;CALM1
acute inflammatory response (GO:0002526),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,F3
regulation of blood coagulation (GO:0030193),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,THBS1
regulation of cardiac muscle cell contraction (GO:0086004),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,PKP2
cellular response to unfolded protein (GO:0034620),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,HSPA5
cellular senescence (GO:0090398),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,ID2
dendritic spine organization (GO:0097061),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,CDC42
entrainment of circadian clock by photoperiod (GO:0043153),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,ID2
L-alpha-amino acid transmembrane transport (GO:1902475),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,SLC1A3
microtubule polymerization or depolymerization (GO:0031109),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,STMN2
negative regulation of cation channel activity (GO:2001258),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,CALM1
negative regulation of protein polymerization (GO:0032272),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,STMN2
positive regulation of gene silencing by miRNA (GO:2000637),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,LIN28A
positive regulation of muscle cell differentiation (GO:0051149),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,CDC42
positive regulation of nitric oxide biosynthetic process (GO:0045429),27-Jan,0.236751338,0.370114018,0,0,3.841297591,5.534329897,CLU
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),3/170,0.239761521,0.374444679,0,0,1.799523402,2.569918286,CLDN6;EMB;PTPRF
organelle organization (GO:0006996),6/420,0.241309739,0.374444679,0,0,1.455808365,2.069684822,CNN2;CDC42;RAB31;ABI2;DPYSL2;TPM1
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),3/171,0.242407427,0.374444679,0,0,1.788720845,2.534859603,GJA1;LGALS1;FLNA
intracellular protein transport (GO:0006886),5/336,0.243658934,0.374444679,0,0,1.516024543,2.140605194,POM121;RAB31;ARL5C;AP1M2;IPO5
amide transport (GO:0042886),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,PDPN
receptor clustering (GO:0043113),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,FLNA
carbohydrate derivative biosynthetic process (GO:1901137),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,TPI1
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,SPRED1
regulation of multicellular organismal development (GO:2000026),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,DUSP6
regulation of phosphatase activity (GO:0010921),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,HSP90B1
regulation of postsynapse organization (GO:0099175),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,ABI2
regulation of small molecule metabolic process (GO:0062012),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,PDK1
glycogen metabolic process (GO:0005977),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,CALM1
response to ketone (GO:1901654),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,THBS1
mucosal immune response (GO:0002385),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,PLA2G1B
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,CALM1
neutral amino acid transport (GO:0015804),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,SLC38A2
photoperiodism (GO:0009648),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,ID2
positive regulation of nitric oxide metabolic process (GO:1904407),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,CLU
protein localization to cell surface (GO:0034394),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,FLNA
protein localization to Golgi apparatus (GO:0034067),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,ARL5C
protein localization to lysosome (GO:0061462),28-Jan,0.244355917,0.374444679,0,0,3.698840254,5.212144694,NEDD4
regulation of calcium ion transmembrane transporter activity (GO:1901019),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,CALM1
regulation of response to biotic stimulus (GO:0002831),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,FOXP1
establishment of endothelial barrier (GO:0061028),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,AFDN
establishment of mitotic spindle localization (GO:0040001),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,GJA1
regulation of ubiquitin-protein transferase activity (GO:0051438),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,FEM1B
limb development (GO:0060173),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,GLI3
lipid catabolic process (GO:0016042),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,PLA2G1B
transition metal ion homeostasis (GO:0055076),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,SLC40A1
negative regulation of epithelial to mesenchymal transition (GO:0010719),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,SPRED1
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,CUL4B
positive regulation of dephosphorylation (GO:0035306),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,CALM1
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,THBS1
positive regulation of viral genome replication (GO:0045070),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,LARP1
production of miRNAs involved in gene silencing by miRNA (GO:0035196),29-Jan,0.251885106,0.381183144,0,0,3.566558442,4.917507384,LIN28A
defense response to bacterium (GO:0042742),3/176,0.255706215,0.386622352,0,0,1.736581338,2.368221277,ANXA3;PLA2G1B;GBP2
response to UV (GO:0009411),2/99,0.258686571,0.386627085,0,0,2.062274321,2.78847968,NEDD4;PCLAF
artery morphogenesis (GO:0048844),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,LRP2
cardiac muscle cell action potential (GO:0086001),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,PKP2
regulation of macrophage activation (GO:0043030),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,THBS1
establishment of spindle orientation (GO:0051294),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,GJA1
regulation of striated muscle contraction (GO:0006942),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,CALM1
fatty-acyl-CoA biosynthetic process (GO:0046949),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,ACSL4
respiratory tube development (GO:0030323),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,PDPN
ion homeostasis (GO:0050801),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,FHL1
termination of RNA polymerase I transcription (GO:0006363),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,CAVIN1
morphogenesis of an epithelium (GO:0002009),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,ACTB
ncRNA catabolic process (GO:0034661),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,LIN28A
phosphatidylcholine acyl-chain remodeling (GO:0036151),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,PLA2G1B
positive regulation of DNA recombination (GO:0045911),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,ARID2
positive regulation of phosphate metabolic process (GO:0045937),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,THBS1
primary neural tube formation (GO:0014020),30-Jan,0.259339647,0.386627085,0,0,3.443399512,4.64726948,LRP2
positive regulation of protein localization to membrane (GO:1905477),2/101,0.266062067,0.392818801,0,0,2.020407117,2.675070871,SFN;YWHAZ
'de novo' posttranslational protein folding (GO:0051084),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,HSPA5
aminoglycan catabolic process (GO:0006026),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,GPC3
regulation of potassium ion transport (GO:0043266),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,FHL1
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,FSTL1
tube closure (GO:0060606),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,LRP2
vitamin transport (GO:0051180),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,PDPN
negative regulation of axon extension (GO:0030517),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,SEMA3E
negative regulation of osteoblast differentiation (GO:0045668),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,NOCT
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,INPP5F
negative regulation of response to DNA damage stimulus (GO:2001021),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,CLU
organelle transport along microtubule (GO:0072384),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,CDC42
peptide cross-linking (GO:0018149),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,THBS1
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),31-Jan,0.266720277,0.392818801,0,0,3.328451178,4.398730697,CLU
cellular response to DNA damage stimulus (GO:0006974),5/350,0.269874206,0.397060583,0,0,1.453458838,1.903739414,CBX5;PCLAF;SFN;FOXP1;CUL4B
chromatin remodeling (GO:0006338),2/103,0.273437585,0.397060583,0,0,1.98019802,2.567686914,NUDT5;ACTB
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,THBS1
regulation of cell morphogenesis (GO:0022604),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,PDPN
regulation of chemotaxis (GO:0050920),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,THBS1
regulation of dendrite morphogenesis (GO:0048814),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,NEDD4
regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,ABI2
cellular response to glucose stimulus (GO:0071333),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,LIN28A
cellular response to topologically incorrect protein (GO:0035967),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,HSPA5
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,STRN3
regulation of intracellular protein transport (GO:0033157),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,PTPN14
endodermal cell differentiation (GO:0035987),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,LAMB1
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,CDC42
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,ID2
transcription initiation from RNA polymerase I promoter (GO:0006361),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,CAVIN1
metal ion export (GO:0070839),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,SLC40A1
mitochondrial membrane organization (GO:0007006),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,BNIP3
negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,STMN2
positive regulation of glucose transmembrane transport (GO:0010828),1/32,0.274027726,0.397060583,0,0,3.220918866,4.169563174,BRAF
apoptotic cell clearance (GO:0043277),1/33,0.281262715,0.405132432,0,0,3.120107323,3.957750418,THBS1
lytic vacuole organization (GO:0080171),1/33,0.281262715,0.405132432,0,0,3.120107323,3.957750418,CLN6
vasculogenesis (GO:0001570),1/33,0.281262715,0.405132432,0,0,3.120107323,3.957750418,SPRED1
negative chemotaxis (GO:0050919),1/33,0.281262715,0.405132432,0,0,3.120107323,3.957750418,SEMA3E
negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.281262715,0.405132432,0,0,3.120107323,3.957750418,TPM1
positive regulation of organelle organization (GO:0010638),1/33,0.281262715,0.405132432,0,0,3.120107323,3.957750418,ANXA2
primary alcohol metabolic process (GO:0034308),1/33,0.281262715,0.405132432,0,0,3.120107323,3.957750418,GPD2
regulation of cell cycle process (GO:0010564),2/106,0.284494637,0.409441606,0,0,1.922784069,2.417018169,CDC42;CALM1
regulation of amyloid-beta formation (GO:1902003),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,CLU
autophagosome maturation (GO:0097352),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,CALM1
cardiac muscle contraction (GO:0060048),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,TPM1
regulation of glucose metabolic process (GO:0010906),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,PDK1
response to steroid hormone (GO:0048545),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,THBS1
transcription by RNA polymerase I (GO:0006360),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,CAVIN1
tRNA export from nucleus (GO:0006409),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,POM121
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,POM121
negative regulation of blood vessel endothelial cell migration (GO:0043537),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,THBS1
neural tube closure (GO:0001843),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,LRP2
phosphatidylserine metabolic process (GO:0006658),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,PLA2G1B
positive regulation of calcium ion transport into cytosol (GO:0010524),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,PLA2G1B
positive regulation of DNA binding (GO:0043388),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,PLAUR
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,PLAUR
positive regulation of protein dephosphorylation (GO:0035307),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,CALM1
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.28842596,0.409564863,0,0,3.025405571,3.761537767,CALM1
DNA replication (GO:0006260),2/108,0.291857862,0.414093087,0,0,1.886313571,2.322973221,PCLAF;RBMS1
regulation of blood circulation (GO:1903522),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,TPM1
cellular response to amyloid-beta (GO:1904646),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,GJA1
cellular response to hydrogen peroxide (GO:0070301),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,IMPACT
regulation of ion transmembrane transport (GO:0034765),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,NEDD4
respiratory system development (GO:0060541),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,PDPN
response to estrogen (GO:0043627),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,KRT19
smoothened signaling pathway (GO:0007224),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,GLI3
lung development (GO:0030324),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,PDPN
negative regulation of cell cycle G1/S phase transition (GO:1902807),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,FHL1
negative regulation of epithelial cell migration (GO:0010633),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,THBS1
negative regulation of Ras protein signal transduction (GO:0046580),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,SPRY4
oxoacid metabolic process (GO:0043436),1/35,0.295518167,0.415138464,0,0,2.93627451,3.579391928,PPA1
regulation of protein kinase activity (GO:0045859),2/110,0.299211521,0.419811259,0,0,1.851193833,2.233658859,SPRED1;SFN
plasma membrane bounded cell projection assembly (GO:0120031),4/278,0.299881345,0.419811259,0,0,1.461875351,1.760636474,PMP22;FLNA;PARVA;AIF1L
regulation of androgen receptor signaling pathway (GO:0060765),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,FOXP1
regulation of cardiac muscle contraction (GO:0055117),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,CALM1
regulation of cell cycle G1/S phase transition (GO:1902806),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,ID2
regulation of embryonic development (GO:0045995),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,RPS6KA6
cellular response to heat (GO:0034605),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,THBS1
dendrite morphogenesis (GO:0048813),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,CDC42
embryonic limb morphogenesis (GO:0030326),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,GLI3
endoderm formation (GO:0001706),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,LAMB1
retina homeostasis (GO:0001895),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,ACTB
mitochondrion disassembly (GO:0061726),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,BNIP3
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,CALM1
negative regulation of DNA metabolic process (GO:0051053),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,DNMT3L
positive regulation of myeloid leukocyte differentiation (GO:0002763),1/36,0.302540039,0.419811259,0,0,2.852236652,3.409967713,ID2
regulation of protein serine/threonine kinase activity (GO:0071900),2/111,0.302883979,0.419946542,0,0,1.834117264,2.190679665,CALM1;ACTB
cellular response to tumor necrosis factor (GO:0071356),3/194,0.304260101,0.421511554,0,0,1.571481996,1.869862975,TMSB4X;ACTN4;GBP2
regulation of cytoskeleton organization (GO:0051493),2/112,0.306553116,0.423594238,0,0,1.817351177,2.148771044,CAPN2;RHOBTB3
phosphatidylinositol metabolic process (GO:0046488),2/112,0.306553116,0.423594238,0,0,1.817351177,2.148771044,INPP5F;PLA2G1B
regulation of glucose import (GO:0046324),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,PLA2G1B
regulation of microtubule cytoskeleton organization (GO:0070507),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,STMN2
regulation of transport (GO:0051049),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,ACTB
skeletal muscle tissue development (GO:0007519),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,ACTA1
lysosome localization (GO:0032418),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,MYH9
tRNA transport (GO:0051031),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,POM121
negative regulation of endothelial cell proliferation (GO:0001937),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,THBS1
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,FHL1
neural crest cell migration (GO:0001755),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,SEMA3E
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,CUL4B
phagosome maturation (GO:0090382),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,RAB31
positive regulation of calcium ion transport (GO:0051928),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,PLA2G1B
positive regulation of cytokinesis (GO:0032467),1/37,0.309492269,0.423594238,0,0,2.772867565,3.252080546,CDC42
cellular response to transforming growth factor beta stimulus (GO:0071560),2/114,0.31388025,0.429255173,0,0,1.784717186,2.068029859,ZYX;CGN
response to estradiol (GO:0032355),1/38,0.316375544,0.43025054,0,0,2.697788698,3.104683599,STRN3
lysosome organization (GO:0007040),1/38,0.316375544,0.43025054,0,0,2.697788698,3.104683599,CLN6
tRNA aminoacylation (GO:0043039),1/38,0.316375544,0.43025054,0,0,2.697788698,3.104683599,PPA1
ncRNA export from nucleus (GO:0097064),1/38,0.316375544,0.43025054,0,0,2.697788698,3.104683599,POM121
negative regulation of endothelial cell migration (GO:0010596),1/38,0.316375544,0.43025054,0,0,2.697788698,3.104683599,THBS1
negative regulation of G0 to G1 transition (GO:0070317),1/38,0.316375544,0.43025054,0,0,2.697788698,3.104683599,CBX5
positive regulation of cell development (GO:0010720),1/38,0.316375544,0.43025054,0,0,2.697788698,3.104683599,LRP2
tumor necrosis factor-mediated signaling pathway (GO:0033209),2/116,0.321190626,0.434661948,0,0,1.753228248,1.991177231,TMSB4X;ACTN4
regulation of dendrite development (GO:0050773),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,NEDD4
cellular response to ketone (GO:1901655),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,LARP1
regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,PKP2
regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,CALM1
regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,CLU
regulation of viral entry into host cell (GO:0046596),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,LGALS1
membrane protein proteolysis (GO:0033619),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,MYH9
vesicle cytoskeletal trafficking (GO:0099518),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,ACTN4
"nucleotide-excision repair, DNA incision (GO:0033683)",1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,CUL4B
odontogenesis (GO:0042476),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,LAMB1
organophosphate biosynthetic process (GO:0090407),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,TPI1
phospholipid dephosphorylation (GO:0046839),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,INPP5F
positive regulation of intracellular transport (GO:0032388),1/39,0.323190545,0.434661948,0,0,2.62666135,2.966848688,NEDD4
negative regulation of response to external stimulus (GO:0032102),2/118,0.328482042,0.439573306,0,0,1.722825136,1.917974894,INPP5F;ENPP3
positive regulation of protein-containing complex assembly (GO:0031334),2/118,0.328482042,0.439573306,0,0,1.722825136,1.917974894,CLU;CUL4B
axon guidance (GO:0007411),3/203,0.328731514,0.439573306,0,0,1.500076531,1.668856034,SEMA3E;EMB;PDLIM7
autophagy of mitochondrion (GO:0000422),1/40,0.329937945,0.439573306,0,0,2.559181559,2.83775023,BNIP3
bone development (GO:0060348),1/40,0.329937945,0.439573306,0,0,2.559181559,2.83775023,GJA1
regulation of microtubule polymerization (GO:0031113),1/40,0.329937945,0.439573306,0,0,2.559181559,2.83775023,STMN2
digestive tract development (GO:0048565),1/40,0.329937945,0.439573306,0,0,2.559181559,2.83775023,GLI3
regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.329937945,0.439573306,0,0,2.559181559,2.83775023,CLU
regulation of sodium ion transmembrane transporter activity (GO:2000649),1/40,0.329937945,0.439573306,0,0,2.559181559,2.83775023,NEDD4
negative regulation of ERBB signaling pathway (GO:1901185),1/40,0.329937945,0.439573306,0,0,2.559181559,2.83775023,CDC42
positive regulation of double-strand break repair (GO:2000781),1/40,0.329937945,0.439573306,0,0,2.559181559,2.83775023,ARID2
positive regulation of wound healing (GO:0090303),1/40,0.329937945,0.439573306,0,0,2.559181559,2.83775023,THBS1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),2/119,0.332119978,0.442134721,0,0,1.708013363,1.882673094,BEX3;F3
regulation of filopodium assembly (GO:0051489),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,CDC42
regulation of G0 to G1 transition (GO:0070316),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,CBX5
cortical cytoskeleton organization (GO:0030865),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,RHOBTB3
epithelial cell migration (GO:0010631),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,FSTL1
regulation of response to DNA damage stimulus (GO:2001020),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,FEM1B
heart contraction (GO:0060047),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,TPM1
response to growth factor (GO:0070848),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,LRP2
hexose metabolic process (GO:0019318),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,ALDOA
keratinocyte differentiation (GO:0030216),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,TXNIP
T cell differentiation (GO:0030217),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,GLI3
negative regulation of cell-cell adhesion (GO:0022408),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,EPCAM
nucleobase-containing compound catabolic process (GO:0034655),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,NUDT5
positive regulation of cation transmembrane transport (GO:1904064),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,FLNA
positive regulation of TOR signaling (GO:0032008),1/41,0.336618413,0.443274942,0,0,2.495075758,2.7166517,LIN28A
regulation of inflammatory response (GO:0050727),3/206,0.336891239,0.443291637,0,0,1.477681713,1.607710515,TMSB4X;ENPP3;FOXP1
epithelium development (GO:0060429),2/122,0.34299965,0.449207652,0,0,1.665059222,1.781656412,TAGLN;PGK1
ATP-dependent chromatin remodeling (GO:0043044),1/42,0.343232608,0.449207652,0,0,2.434097068,2.602894167,ACTB
regulation of chemokine production (GO:0032642),1/42,0.343232608,0.449207652,0,0,2.434097068,2.602894167,FOXP1
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),1/42,0.343232608,0.449207652,0,0,2.434097068,2.602894167,CLU
translesion synthesis (GO:0019985),1/42,0.343232608,0.449207652,0,0,2.434097068,2.602894167,PCLAF
negative regulation of protein catabolic process (GO:0042177),1/42,0.343232608,0.449207652,0,0,2.434097068,2.602894167,FLNA
positive regulation of ATPase activity (GO:0032781),1/42,0.343232608,0.449207652,0,0,2.434097068,2.602894167,TPM1
regulation of anatomical structure morphogenesis (GO:0022603),2/123,0.346614016,0.452590255,0,0,1.651214498,1.749533532,ABI2;NEDD4
cellular response to organic substance (GO:0071310),2/123,0.346614016,0.452590255,0,0,1.651214498,1.749533532,LRP2;PTPN14
positive regulation of epithelial cell proliferation (GO:0050679),2/123,0.346614016,0.452590255,0,0,1.651214498,1.749533532,LAMB1;F3
extracellular matrix organization (GO:0030198),4/300,0.349340955,0.45279067,0,0,1.351697852,1.421589937,COL18A1;CAPN2;LAMB1;THBS1
regulation of carbohydrate catabolic process (GO:0043470),1/43,0.349781184,0.45279067,0,0,2.376022126,2.495886521,POM121
regulation of cell-cell adhesion (GO:0022407),1/43,0.349781184,0.45279067,0,0,2.376022126,2.495886521,AFDN
regulation of cell-substrate adhesion (GO:0010810),1/43,0.349781184,0.45279067,0,0,2.376022126,2.495886521,PDPN
cellular glucose homeostasis (GO:0001678),1/43,0.349781184,0.45279067,0,0,2.376022126,2.495886521,LIN28A
DNA synthesis involved in DNA repair (GO:0000731),1/43,0.349781184,0.45279067,0,0,2.376022126,2.495886521,PCLAF
regulation of purine nucleotide metabolic process (GO:1900542),1/43,0.349781184,0.45279067,0,0,2.376022126,2.495886521,POM121
tRNA aminoacylation for protein translation (GO:0006418),1/43,0.349781184,0.45279067,0,0,2.376022126,2.495886521,PPA1
positive regulation of neuron differentiation (GO:0045666),1/43,0.349781184,0.45279067,0,0,2.376022126,2.495886521,IMPACT
positive regulation of T cell differentiation (GO:0045582),1/43,0.349781184,0.45279067,0,0,2.376022126,2.495886521,GLI3
defense response to symbiont (GO:0140546),2/124,0.350221891,0.45279067,0,0,1.637596738,1.718147419,BNIP3;FLNA
fatty acid metabolic process (GO:0006631),2/124,0.350221891,0.45279067,0,0,1.637596738,1.718147419,PLA2G1B;ACSL4
non-canonical Wnt signaling pathway (GO:0035567),2/124,0.350221891,0.45279067,0,0,1.637596738,1.718147419,CDC42;CALM1
protein targeting (GO:0006605),2/125,0.35382305,0.455078863,0,0,1.624200404,1.687476573,EDEM1;AP1M2
cellular response to oxidative stress (GO:0034599),2/125,0.35382305,0.455078863,0,0,1.624200404,1.687476573,TPM1;PRDX6
regulation of phosphorylation (GO:0042325),2/125,0.35382305,0.455078863,0,0,1.624200404,1.687476573,POM121;THBS1
MAPK cascade (GO:0000165),4/303,0.356113069,0.455078863,0,0,1.337929852,1.381421922,SPRED1;BRAF;CALM1;DUSP6
antibacterial humoral response (GO:0019731),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,PLA2G1B
branching morphogenesis of an epithelial tube (GO:0048754),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,SEMA3E
regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,THBS1
embryonic organ morphogenesis (GO:0048562),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,ID2
response to amyloid-beta (GO:1904645),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,GJA1
intracellular protein transmembrane transport (GO:0065002),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,HSPA5
intracellular steroid hormone receptor signaling pathway (GO:0030518),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,NEDD4
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,CDC42
positive regulation of cell division (GO:0051781),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,CDC42
positive regulation of cell-matrix adhesion (GO:0001954),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,S100A10
positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,FLNA
protein K63-linked ubiquitination (GO:0070534),1/44,0.35626479,0.455078863,0,0,2.320648344,2.395097137,NEDD4
negative regulation of multicellular organismal process (GO:0051241),3/214,0.358617805,0.457398757,0,0,1.421075539,1.457310221,GJA1;RPS6KA6;SPRED1
positive regulation of GTPase activity (GO:0043547),3/214,0.358617805,0.457398757,0,0,1.421075539,1.457310221,AFDN;ARHGAP29;S100A10
neural crest cell development (GO:0014032),1/45,0.362684067,0.461548656,0,0,2.267791552,2.30004672,SEMA3E
positive regulation of nervous system development (GO:0051962),1/45,0.362684067,0.461548656,0,0,2.267791552,2.30004672,LRP2
protein deacetylation (GO:0006476),1/45,0.362684067,0.461548656,0,0,2.267791552,2.30004672,FLNA
extracellular structure organization (GO:0043062),3/216,0.364036568,0.462924114,0,0,1.407588387,1.422369408,COL18A1;LAMB1;THBS1
external encapsulating structure organization (GO:0045229),3/217,0.366743353,0.466018399,0,0,1.400939348,1.405272433,COL18A1;LAMB1;THBS1
phosphorylation (GO:0016310),5/400,0.367167162,0.466155347,0,0,1.266214276,1.268668267,GMFB;PGK1;BRAF;YWHAZ;PDK1
regulation of cellular protein localization (GO:1903827),1/46,0.36903965,0.466155347,0,0,2.217283951,2.210302143,GPC3
regulation of double-strand break repair via homologous recombination (GO:0010569),1/46,0.36903965,0.466155347,0,0,2.217283951,2.210302143,ARID2
erythrocyte differentiation (GO:0030218),1/46,0.36903965,0.466155347,0,0,2.217283951,2.210302143,ID2
positive regulation of organelle assembly (GO:1902117),1/46,0.36903965,0.466155347,0,0,2.217283951,2.210302143,G3BP2
positive regulation of response to stimulus (GO:0048584),1/46,0.36903965,0.466155347,0,0,2.217283951,2.210302143,PLA2G1B
postreplication repair (GO:0006301),1/46,0.36903965,0.466155347,0,0,2.217283951,2.210302143,PCLAF
posttranscriptional regulation of gene expression (GO:0010608),1/46,0.36903965,0.466155347,0,0,2.217283951,2.210302143,LARP1
regulation of primary metabolic process (GO:0080090),2/130,0.371720443,0.46884651,0,0,1.560358503,1.544151377,ID2;ODC1
Golgi organization (GO:0007030),2/130,0.371720443,0.46884651,0,0,1.560358503,1.544151377,CDC42;YWHAZ
protein phosphorylation (GO:0006468),6/496,0.372435312,0.469400719,0,0,1.225187692,1.210107976,RPS6KA6;GMFB;ABI2;BRAF;YWHAZ;PDK1
cellular response to hypoxia (GO:0071456),2/131,0.375276785,0.470615167,0,0,1.548184,1.517361873,BNIP3;PGK1
cellular response to metal ion (GO:0071248),2/131,0.375276785,0.470615167,0,0,1.548184,1.517361873,BNIP3;BRAF
regulation of DNA binding (GO:0051101),1/47,0.375332167,0.470615167,0,0,2.168972332,2.125471134,PLAUR
epidermal growth factor receptor signaling pathway (GO:0007173),1/47,0.375332167,0.470615167,0,0,2.168972332,2.125471134,BRAF
glycosphingolipid metabolic process (GO:0006687),1/47,0.375332167,0.470615167,0,0,2.168972332,2.125471134,CLN6
polyol metabolic process (GO:0019751),1/47,0.375332167,0.470615167,0,0,2.168972332,2.125471134,CALM1
positive regulation of neuron death (GO:1901216),1/47,0.375332167,0.470615167,0,0,2.168972332,2.125471134,CLU
cellular response to alcohol (GO:0097306),1/48,0.381562241,0.476673064,0,0,2.122716527,2.045197663,LARP1
cellular response to ionizing radiation (GO:0071479),1/48,0.381562241,0.476673064,0,0,2.122716527,2.045197663,CRYAB
inositol phosphate metabolic process (GO:0043647),1/48,0.381562241,0.476673064,0,0,2.122716527,2.045197663,CALM1
negative regulation of MAP kinase activity (GO:0043407),1/48,0.381562241,0.476673064,0,0,2.122716527,2.045197663,SPRY4
phosphatidic acid biosynthetic process (GO:0006654),1/48,0.381562241,0.476673064,0,0,2.122716527,2.045197663,PLA2G1B
defense response to virus (GO:0051607),2/133,0.382364752,0.476976236,0,0,1.524392607,1.465520986,BNIP3;FLNA
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),2/133,0.382364752,0.476976236,0,0,1.524392607,1.465520986,ZYX;CGN
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),3/224,0.385631625,0.480699554,0,0,1.356080894,1.292172467,GJA1;LGALS1;FLNA
aminoglycan biosynthetic process (GO:0006023),1/49,0.38773049,0.480853533,0,0,2.078388047,1.969157937,GPC3
response to hydrogen peroxide (GO:0042542),1/49,0.38773049,0.480853533,0,0,2.078388047,1.969157937,IMPACT
response to unfolded protein (GO:0006986),1/49,0.38773049,0.480853533,0,0,2.078388047,1.969157937,HSPA5
mitotic cytokinesis (GO:0000281),1/49,0.38773049,0.480853533,0,0,2.078388047,1.969157937,MYH10
negative regulation of catabolic process (GO:0009895),1/49,0.38773049,0.480853533,0,0,2.078388047,1.969157937,FLNA
negative regulation of cell projection organization (GO:0031345),1/49,0.38773049,0.480853533,0,0,2.078388047,1.969157937,STMN2
positive regulation of reactive oxygen species metabolic process (GO:2000379),1/49,0.38773049,0.480853533,0,0,2.078388047,1.969157937,THBS1
regulation of complement activation (GO:0030449),1/50,0.393837523,0.486303723,0,0,2.035868893,1.897056907,CLU
regulation of generation of precursor metabolites and energy (GO:0043467),1/50,0.393837523,0.486303723,0,0,2.035868893,1.897056907,POM121
chloride transmembrane transport (GO:1902476),1/50,0.393837523,0.486303723,0,0,2.035868893,1.897056907,SLC1A3
iron ion transport (GO:0006826),1/50,0.393837523,0.486303723,0,0,2.035868893,1.897056907,SLC40A1
neuron migration (GO:0001764),1/50,0.393837523,0.486303723,0,0,2.035868893,1.897056907,MAP1B
phosphatidic acid metabolic process (GO:0046473),1/50,0.393837523,0.486303723,0,0,2.035868893,1.897056907,PLA2G1B
regulation of cellular amine metabolic process (GO:0033238),1/51,0.399883944,0.490570368,0,0,1.995050505,1.828625215,ODC1
regulation of epithelial cell migration (GO:0010632),1/51,0.399883944,0.490570368,0,0,1.995050505,1.828625215,GLIPR2
DNA duplex unwinding (GO:0032508),1/51,0.399883944,0.490570368,0,0,1.995050505,1.828625215,CUL4B
regulation of protein modification process (GO:0031399),1/51,0.399883944,0.490570368,0,0,1.995050505,1.828625215,SPRED1
inositol lipid-mediated signaling (GO:0048017),1/51,0.399883944,0.490570368,0,0,1.995050505,1.828625215,INPP5F
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.399883944,0.490570368,0,0,1.995050505,1.828625215,SFN
mitotic nuclear membrane organization (GO:0101024),1/51,0.399883944,0.490570368,0,0,1.995050505,1.828625215,POM121
mitotic nuclear membrane reassembly (GO:0007084),1/51,0.399883944,0.490570368,0,0,1.995050505,1.828625215,POM121
negative regulation of transport (GO:0051051),1/51,0.399883944,0.490570368,0,0,1.995050505,1.828625215,CRYAB
cellular protein metabolic process (GO:0044267),5/417,0.400700274,0.491218177,0,0,1.212904114,1.109251243,LGALS1;GPC3;LAMB1;FSTL1;HSP90B1
regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/52,0.405870353,0.496841294,0,0,1.955832838,1.763616516,PLAUR
regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.405870353,0.496841294,0,0,1.955832838,1.763616516,CALM1
regulation of small GTPase mediated signal transduction (GO:0051056),2/141,0.410360775,0.501933241,0,0,1.436073476,1.279137309,CDC42;ARHGAP29
cardiac muscle tissue development (GO:0048738),1/53,0.411797342,0.501933241,0,0,1.918123543,1.701805125,GJA1
regulation of immune effector process (GO:0002697),1/53,0.411797342,0.501933241,0,0,1.918123543,1.701805125,CLU
epidermal cell differentiation (GO:0009913),1/53,0.411797342,0.501933241,0,0,1.918123543,1.701805125,TXNIP
positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.411797342,0.501933241,0,0,1.918123543,1.701805125,ACTN4
positive regulation of phagocytosis (GO:0050766),1/53,0.411797342,0.501933241,0,0,1.918123543,1.701805125,RAB31
cellular protein localization (GO:0034613),4/329,0.414596562,0.504983947,0,0,1.229254438,1.082296296,GJA1;RAB31;ARL5C;FLNA
monocarboxylic acid metabolic process (GO:0032787),2/143,0.417264205,0.50582943,0,0,1.415559636,1.23724962,LDHA;ACSL4
regulation of cellular amino acid metabolic process (GO:0006521),1/54,0.417665498,0.50582943,0,0,1.88183724,1.642983941,ODC1
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/54,0.417665498,0.50582943,0,0,1.88183724,1.642983941,ACTB
regulation of humoral immune response (GO:0002920),1/54,0.417665498,0.50582943,0,0,1.88183724,1.642983941,CLU
regulation of megakaryocyte differentiation (GO:0045652),1/54,0.417665498,0.50582943,0,0,1.88183724,1.642983941,THBS1
inorganic anion transport (GO:0015698),1/54,0.417665498,0.50582943,0,0,1.88183724,1.642983941,ENPP3
nuclear membrane reassembly (GO:0031468),1/54,0.417665498,0.50582943,0,0,1.88183724,1.642983941,POM121
positive regulation of leukocyte chemotaxis (GO:0002690),1/54,0.417665498,0.50582943,0,0,1.88183724,1.642983941,THBS1
protein sumoylation (GO:0016925),1/55,0.423475402,0.511049635,0,0,1.846894875,1.586962613,POM121
regulation of gene silencing by RNA (GO:0060966),1/55,0.423475402,0.511049635,0,0,1.846894875,1.586962613,POM121
ceramide metabolic process (GO:0006672),1/55,0.423475402,0.511049635,0,0,1.846894875,1.586962613,CLN6
regulation of posttranscriptional gene silencing (GO:0060147),1/55,0.423475402,0.511049635,0,0,1.846894875,1.586962613,POM121
positive regulation of response to DNA damage stimulus (GO:2001022),1/55,0.423475402,0.511049635,0,0,1.846894875,1.586962613,SPRED1
positive regulation of cytokine production (GO:0001819),4/335,0.4279629,0.515745086,0,0,1.206600046,1.024064107,PLA2G1B;LRRFIP1;F3;FOXP1
regulation of ATP metabolic process (GO:1903578),1/56,0.429227629,0.515745086,0,0,1.81322314,1.533565923,POM121
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/56,0.429227629,0.515745086,0,0,1.81322314,1.533565923,SFN
glycosaminoglycan catabolic process (GO:0006027),1/56,0.429227629,0.515745086,0,0,1.81322314,1.533565923,GPC3
mitochondrial transport (GO:0006839),1/56,0.429227629,0.515745086,0,0,1.81322314,1.533565923,BNIP3
peptidyl-tyrosine modification (GO:0018212),1/56,0.429227629,0.515745086,0,0,1.81322314,1.533565923,ABI2
positive regulation of cellular process (GO:0048522),7/625,0.429484905,0.515745086,0,0,1.131683185,0.956463189,CDC42;EPCAM;PLA2G1B;PDPN;TPM1;ACTN4;THBS1
carboxylic acid transport (GO:0046942),1/57,0.434922749,0.520076045,0,0,1.780753968,1.482632341,SLC38A2
cellular response to peptide (GO:1901653),1/57,0.434922749,0.520076045,0,0,1.780753968,1.482632341,GJA1
regulation of reactive oxygen species metabolic process (GO:2000377),1/57,0.434922749,0.520076045,0,0,1.780753968,1.482632341,THBS1
negative regulation of cell cycle G2/M phase transition (GO:1902750),1/57,0.434922749,0.520076045,0,0,1.780753968,1.482632341,FHL1
positive regulation of cell junction assembly (GO:1901890),1/57,0.434922749,0.520076045,0,0,1.780753968,1.482632341,S100A10
"positive regulation of gene expression, epigenetic (GO:0045815)",1/57,0.434922749,0.520076045,0,0,1.780753968,1.482632341,ACTB
regulation of G2/M transition of mitotic cell cycle (GO:0010389),2/149,0.437726269,0.523061405,0,0,1.357367312,1.121404641,TUBA1A;FHL1
anterograde trans-synaptic signaling (GO:0098916),3/244,0.4387616,0.523931161,0,0,1.242272843,1.023383207,PMP22;SLC1A3;CALM1
cellular iron ion homeostasis (GO:0006879),1/58,0.440561326,0.525343947,0,0,1.749424065,1.434012745,SLC40A1
negative regulation of neuron projection development (GO:0010977),1/58,0.440561326,0.525343947,0,0,1.749424065,1.434012745,STMN2
response to reactive oxygen species (GO:0000302),1/59,0.446143919,0.531628838,0,0,1.719174504,1.387569278,TPM1
positive regulation of multicellular organismal process (GO:0051240),4/345,0.450061706,0.535922534,0,0,1.170614332,0.934584045,GJA1;GLIPR2;PDPN;ENO1
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.451671081,0.536713753,0,0,1.689950351,1.343174333,FLNA
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.451671081,0.536713753,0,0,1.689950351,1.343174333,EMB
ribonucleoprotein complex biogenesis (GO:0022613),1/60,0.451671081,0.536713753,0,0,1.689950351,1.343174333,CUL4B
positive regulation of protein kinase activity (GO:0045860),2/154,0.454478372,0.539673273,0,0,1.312383115,1.034951824,CALM1;CLU
B cell differentiation (GO:0030183),1/61,0.457143359,0.540577574,0,0,1.661700337,1.300709633,KLF6
regulation of endocytosis (GO:0030100),1/61,0.457143359,0.540577574,0,0,1.661700337,1.300709633,GPC3
response to light stimulus (GO:0009416),1/61,0.457143359,0.540577574,0,0,1.661700337,1.300709633,PCLAF
iron ion homeostasis (GO:0055072),1/61,0.457143359,0.540577574,0,0,1.661700337,1.300709633,SLC40A1
negative regulation of response to stimulus (GO:0048585),1/61,0.457143359,0.540577574,0,0,1.661700337,1.300709633,CLU
pattern recognition receptor signaling pathway (GO:0002221),1/61,0.457143359,0.540577574,0,0,1.661700337,1.300709633,HSP90B1
positive regulation of NF-kappaB transcription factor activity (GO:0051092),2/155,0.457794723,0.540972406,0,0,1.303739093,1.018656198,PLA2G1B;CLU
regulation of canonical Wnt signaling pathway (GO:0060828),3/253,0.462119052,0.545470206,0,0,1.197,0.924003482,CTNND1;GPC3;GLI3
regulation of neurogenesis (GO:0050767),1/62,0.462561296,0.545470206,0,0,1.634376552,1.260065423,LRP2
positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/62,0.462561296,0.545470206,0,0,1.634376552,1.260065423,PERP
mitotic spindle organization (GO:0007052),2/157,0.464392527,0.547250945,0,0,1.286785656,0.986996923,STAG2;FLNA
cellular response to growth factor stimulus (GO:0071363),2/158,0.467673787,0.548757694,0,0,1.278471951,0.971618564,STMN2;LRP2
cellular response to starvation (GO:0009267),2/158,0.467673787,0.548757694,0,0,1.278471951,0.971618564,IMPACT;HSPA5
cell cycle G1/S phase transition (GO:0044843),1/63,0.467925428,0.548757694,0,0,1.607934181,1.221139724,CUL4B
monocarboxylic acid biosynthetic process (GO:0072330),1/63,0.467925428,0.548757694,0,0,1.607934181,1.221139724,PLA2G1B
organonitrogen compound catabolic process (GO:1901565),1/63,0.467925428,0.548757694,0,0,1.607934181,1.221139724,CLN6
positive regulation of DNA metabolic process (GO:0051054),1/63,0.467925428,0.548757694,0,0,1.607934181,1.221139724,DNMT3L
positive regulation of viral process (GO:0048524),1/63,0.467925428,0.548757694,0,0,1.607934181,1.221139724,LARP1
response to lipopolysaccharide (GO:0032496),2/159,0.47094316,0.551916881,0,0,1.270264153,0.956531609,NOCT;FOXP1
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.473236288,0.55308274,0,0,1.582331249,1.183837681,PLA2G1B
regulation of cellular ketone metabolic process (GO:0010565),1/64,0.473236288,0.55308274,0,0,1.582331249,1.183837681,ODC1
negative regulation of cell cycle process (GO:0010948),1/64,0.473236288,0.55308274,0,0,1.582331249,1.183837681,CBX5
plasma membrane organization (GO:0007009),1/64,0.473236288,0.55308274,0,0,1.582331249,1.183837681,MYH9
cellular response to type I interferon (GO:0071357),1/65,0.478494401,0.557316787,0,0,1.557528409,1.148070963,GBP2
regulation of RNA metabolic process (GO:0051252),1/65,0.478494401,0.557316787,0,0,1.557528409,1.148070963,ESRP1
inorganic anion transmembrane transport (GO:0098661),1/65,0.478494401,0.557316787,0,0,1.557528409,1.148070963,SLC1A3
type I interferon signaling pathway (GO:0060337),1/65,0.478494401,0.557316787,0,0,1.557528409,1.148070963,GBP2
mitotic G1 DNA damage checkpoint signaling (GO:0031571),1/65,0.478494401,0.557316787,0,0,1.557528409,1.148070963,SFN
cellular component disassembly (GO:0022411),1/66,0.483700289,0.561079165,0,0,1.533488733,1.113757227,CAPN2
embryonic organ development (GO:0048568),1/66,0.483700289,0.561079165,0,0,1.533488733,1.113757227,GLI3
regulation of protein localization (GO:0032880),1/66,0.483700289,0.561079165,0,0,1.533488733,1.113757227,AFDN
ERBB signaling pathway (GO:0038127),1/66,0.483700289,0.561079165,0,0,1.533488733,1.113757227,BRAF
extracellular matrix disassembly (GO:0022617),1/66,0.483700289,0.561079165,0,0,1.533488733,1.113757227,CAPN2
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),1/66,0.483700289,0.561079165,0,0,1.533488733,1.113757227,FHL1
protein N-linked glycosylation (GO:0006487),1/67,0.488854469,0.565134338,0,0,1.510177533,1.080819629,GFPT2
anion transmembrane transport (GO:0098656),1/67,0.488854469,0.565134338,0,0,1.510177533,1.080819629,SLC1A3
regulation of gene silencing by miRNA (GO:0060964),1/67,0.488854469,0.565134338,0,0,1.510177533,1.080819629,POM121
regulation of viral genome replication (GO:0045069),1/67,0.488854469,0.565134338,0,0,1.510177533,1.080819629,LARP1
vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/67,0.488854469,0.565134338,0,0,1.510177533,1.080819629,CDC42
regulation of neuron projection development (GO:0010975),2/165,0.490305019,0.566043193,0,0,1.22313226,0.871760112,ABI2;STMN2
negative regulation of canonical Wnt signaling pathway (GO:0090090),2/165,0.490305019,0.566043193,0,0,1.22313226,0.871760112,CTNND1;GLI3
regulation of MAPK cascade (GO:0043408),2/166,0.49348886,0.568718578,0,0,1.215612232,0.858532208,SPRED1;YWHAZ
regulation of myeloid cell differentiation (GO:0045637),1/68,0.49395745,0.568718578,0,0,1.487562189,1.049186387,THBS1
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.49395745,0.568718578,0,0,1.487562189,1.049186387,INPP5F
interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.49395745,0.568718578,0,0,1.487562189,1.049186387,GBP2
cell chemotaxis (GO:0060326),1/69,0.499009739,0.572986925,0,0,1.465612002,1.018790381,PARVA
cellular response to calcium ion (GO:0071277),1/69,0.499009739,0.572986925,0,0,1.465612002,1.018790381,BRAF
RNA 3'-end processing (GO:0031123),1/69,0.499009739,0.572986925,0,0,1.465612002,1.018790381,LIN28A
peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.499009739,0.572986925,0,0,1.465612002,1.018790381,ABI2
"DNA-templated transcription, initiation (GO:0006352)",2/168,0.499818919,0.573529587,0,0,1.200843985,0.832796602,NR6A1;CAVIN1
cellular response to light stimulus (GO:0071482),1/70,0.504011838,0.576787221,0,0,1.444298053,0.989568788,NEDD4
"DNA-templated transcription, termination (GO:0006353)",1/70,0.504011838,0.576787221,0,0,1.444298053,0.989568788,CAVIN1
regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/70,0.504011838,0.576787221,0,0,1.444298053,0.989568788,CDC42
neutrophil chemotaxis (GO:0030593),1/70,0.504011838,0.576787221,0,0,1.444298053,0.989568788,PLA2G1B
regulation of glycolytic process (GO:0006110),1/71,0.508964242,0.5805054,0,0,1.423593074,0.961462755,POM121
cholesterol homeostasis (GO:0042632),1/71,0.508964242,0.5805054,0,0,1.423593074,0.961462755,SOAT1
fatty acid biosynthetic process (GO:0006633),1/71,0.508964242,0.5805054,0,0,1.423593074,0.961462755,PLA2G1B
regulation of TOR signaling (GO:0032006),1/71,0.508964242,0.5805054,0,0,1.423593074,0.961462755,LIN28A
phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.508964242,0.5805054,0,0,1.423593074,0.961462755,INPP5F
positive regulation of ERK1 and ERK2 cascade (GO:0070374),2/172,0.512326752,0.583949689,0,0,1.172349955,0.784059058,GLIPR2;BRAF
cytoskeleton-dependent cytokinesis (GO:0061640),1/72,0.513867442,0.584142843,0,0,1.403471333,0.934417097,MYH10
sterol homeostasis (GO:0055092),1/72,0.513867442,0.584142843,0,0,1.403471333,0.934417097,SOAT1
negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.513867442,0.584142843,0,0,1.403471333,0.934417097,THBS1
positive regulation of neurogenesis (GO:0050769),1/72,0.513867442,0.584142843,0,0,1.403471333,0.934417097,LRP2
neuron differentiation (GO:0030182),2/174,0.518503594,0.588483463,0,0,1.158599929,0.760978074,ID2;ACSL4
granulocyte chemotaxis (GO:0071621),1/73,0.518721925,0.588483463,0,0,1.38390853,0.908380023,PLA2G1B
transcription-coupled nucleotide-excision repair (GO:0006283),1/73,0.518721925,0.588483463,0,0,1.38390853,0.908380023,CUL4B
negative regulation of cell population proliferation (GO:0008285),4/379,0.522873802,0.592752164,0,0,1.062618803,0.689018122,COL18A1;PDPN;ARID2;PTPN14
cellular response to amino acid starvation (GO:0034198),1/74,0.523528173,0.592752164,0,0,1.364881694,0.883302888,IMPACT
regulation of peptide hormone secretion (GO:0090276),1/74,0.523528173,0.592752164,0,0,1.364881694,0.883302888,SLC2A1
cellular response to cytokine stimulus (GO:0071345),5/482,0.525474926,0.594561271,0,0,1.044111608,0.671836541,GBP2;F3;YWHAZ;PTPN14;HSP90B1
glycerophospholipid biosynthetic process (GO:0046474),2/177,0.527671348,0.596159253,0,0,1.138564177,0.727863169,INPP5F;PLA2G1B
positive regulation of developmental process (GO:0051094),2/177,0.527671348,0.596159253,0,0,1.138564177,0.727863169,GJA1;BNIP3
nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.528286662,0.596159253,0,0,1.346369096,0.859139961,CUL4B
positive regulation of immune response (GO:0050778),1/75,0.528286662,0.596159253,0,0,1.346369096,0.859139961,PLA2G1B
negative regulation of immune response (GO:0050777),2/178,0.53070108,0.598487518,0,0,1.132037379,0.717209475,MYH9;ENPP3
chloride transport (GO:0006821),1/76,0.532997865,0.599886633,0,0,1.328350168,0.835848218,SLC1A3
RNA transport (GO:0050658),1/76,0.532997865,0.599886633,0,0,1.328350168,0.835848218,POM121
positive regulation of growth (GO:0045927),1/76,0.532997865,0.599886633,0,0,1.328350168,0.835848218,CDC42
regulation of immune response (GO:0050776),2/179,0.533717647,0.599904269,0,0,1.12558433,0.706741265,PLA2G1B;FOXP1
RNA processing (GO:0006396),2/179,0.533717647,0.599904269,0,0,1.12558433,0.706741265,LIN28A;RBMS1
positive regulation of cellular biosynthetic process (GO:0031328),2/180,0.536721012,0.601955632,0,0,1.119203787,0.696454607,CLU;THBS1
neutrophil migration (GO:1990266),1/77,0.537662249,0.601955632,0,0,1.310805423,0.81338715,PLA2G1B
phosphatidylcholine metabolic process (GO:0046470),1/77,0.537662249,0.601955632,0,0,1.310805423,0.81338715,PLA2G1B
positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.537662249,0.601955632,0,0,1.310805423,0.81338715,F3
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.537662249,0.601955632,0,0,1.310805423,0.81338715,NEDD4
positive regulation of type I interferon production (GO:0032481),1/77,0.537662249,0.601955632,0,0,1.310805423,0.81338715,LRRFIP1
negative regulation of cytokine production (GO:0001818),2/182,0.542687986,0.607183407,0,0,1.106655386,0.676410719,TMSB4X;THBS1
positive regulation of programmed cell death (GO:0043068),3/286,0.543785642,0.608012292,0,0,1.055635682,0.643093416,BNIP3;CLU;DUSP6
regulation of ion transport (GO:0043269),1/79,0.546852407,0.610240014,0,0,1.277065527,0.770806531,NEDD4
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.546852407,0.610240014,0,0,1.277065527,0.770806531,CLU
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.546852407,0.610240014,0,0,1.277065527,0.770806531,CLU
regulation of organelle organization (GO:0033043),1/80,0.551379094,0.61288322,0,0,1.26083621,0.75061702,CAPN2
regulation of protein localization to plasma membrane (GO:1903076),1/80,0.551379094,0.61288322,0,0,1.26083621,0.75061702,ACTB
response to interferon-gamma (GO:0034341),1/80,0.551379094,0.61288322,0,0,1.26083621,0.75061702,GBP2
lipid biosynthetic process (GO:0008610),1/80,0.551379094,0.61288322,0,0,1.26083621,0.75061702,PLA2G1B
negative regulation of cell cycle (GO:0045786),1/80,0.551379094,0.61288322,0,0,1.26083621,0.75061702,IPO5
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.551379094,0.61288322,0,0,1.26083621,0.75061702,THBS1
regulation of mitotic cell cycle phase transition (GO:1901990),2/188,0.560268594,0.621580516,0,0,1.070629332,0.620257303,TUBA1A;ID2
regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.56029793,0.621580516,0,0,1.229579748,0.712279095,CALM1
positive regulation of cytoskeleton organization (GO:0051495),1/82,0.56029793,0.621580516,0,0,1.229579748,0.712279095,CDC42
regulation of GTPase activity (GO:0043087),2/189,0.563151701,0.624339947,0,0,1.064849752,0.611443368,AFDN;S100A10
regulation of interleukin-1 beta production (GO:0032651),1/83,0.564690965,0.624826886,0,0,1.214523282,0.694071712,FOXP1
regulation of osteoblast differentiation (GO:0045667),1/83,0.564690965,0.624826886,0,0,1.214523282,0.694071712,NOCT
long-chain fatty acid metabolic process (GO:0001676),1/83,0.564690965,0.624826886,0,0,1.214523282,0.694071712,ACSL4
regulation of cell cycle (GO:0051726),3/296,0.567097232,0.627082208,0,0,1.019084767,0.578049853,ID2;PCLAF;THBS1
negative regulation of Wnt signaling pathway (GO:0030178),2/191,0.568877437,0.628008237,0,0,1.053474069,0.594254471,CTNND1;GLI3
lymphocyte differentiation (GO:0030098),1/84,0.569040327,0.628008237,0,0,1.199829622,0.676468708,KLF6
nuclear export (GO:0051168),1/84,0.569040327,0.628008237,0,0,1.199829622,0.676468708,POM121
B cell activation (GO:0042113),1/85,0.573346449,0.630363005,0,0,1.18548581,0.659444408,KLF6
regulation of cell cycle G2/M phase transition (GO:1902749),1/85,0.573346449,0.630363005,0,0,1.18548581,0.659444408,TUBA1A
G1/S transition of mitotic cell cycle (GO:0000082),1/85,0.573346449,0.630363005,0,0,1.18548581,0.659444408,CUL4B
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1/85,0.573346449,0.630363005,0,0,1.18548581,0.659444408,CDC42
negative regulation of defense response (GO:0031348),1/85,0.573346449,0.630363005,0,0,1.18548581,0.659444408,ENPP3
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),4/404,0.573393579,0.630363005,0,0,0.994923077,0.553359227,CDC42;SPRED1;ESRP1;ACTB
regulation of neuron death (GO:1901214),1/86,0.577609759,0.632956289,0,0,1.171479501,0.642974486,CLU
regulation of Ras protein signal transduction (GO:0046578),1/86,0.577609759,0.632956289,0,0,1.171479501,0.642974486,SPRY4
response to interleukin-1 (GO:0070555),1/86,0.577609759,0.632956289,0,0,1.171479501,0.642974486,GBP2
negative regulation of phosphorylation (GO:0042326),1/86,0.577609759,0.632956289,0,0,1.171479501,0.642974486,IMPACT
positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.577609759,0.632956289,0,0,1.171479501,0.642974486,CLU
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.581830679,0.637171901,0,0,1.157798919,0.627035879,IMPACT
regulation of establishment of planar polarity (GO:0090175),1/88,0.58600963,0.639283233,0,0,1.144432834,0.611606715,CDC42
"retrograde transport, endosome to Golgi (GO:0042147)",1/88,0.58600963,0.639283233,0,0,1.144432834,0.611606715,RHOBTB3
sensory perception of mechanical stimulus (GO:0050954),1/88,0.58600963,0.639283233,0,0,1.144432834,0.611606715,LRP2
metal ion transport (GO:0030001),1/88,0.58600963,0.639283233,0,0,1.144432834,0.611606715,LRP2
negative regulation of binding (GO:0051100),1/88,0.58600963,0.639283233,0,0,1.144432834,0.611606715,ACTB
positive regulation of neuron projection development (GO:0010976),1/88,0.58600963,0.639283233,0,0,1.144432834,0.611606715,STMN2
chemical synaptic transmission (GO:0007268),3/306,0.589671176,0.641742522,0,0,0.984946454,0.52023909,PMP22;SLC1A3;CALM1
regulation of cation channel activity (GO:2001257),1/89,0.590147026,0.641742522,0,0,1.131370523,0.596666233,CALM1
collagen fibril organization (GO:0030199),1/89,0.590147026,0.641742522,0,0,1.131370523,0.596666233,COL18A1
regulation of type I interferon production (GO:0032479),1/89,0.590147026,0.641742522,0,0,1.131370523,0.596666233,LRRFIP1
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),1/89,0.590147026,0.641742522,0,0,1.131370523,0.596666233,CUL4B
regulation of macromolecule metabolic process (GO:0060255),2/200,0.593972556,0.644551589,0,0,1.005127416,0.523593147,PEG3;FOXP1
"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.594243279,0.644551589,0,0,1.118601748,0.582194718,PRDX6
positive regulation of binding (GO:0051099),1/90,0.594243279,0.644551589,0,0,1.118601748,0.582194718,PLAUR
protein complex oligomerization (GO:0051259),1/90,0.594243279,0.644551589,0,0,1.118601748,0.582194718,G3BP2
modification-dependent protein catabolic process (GO:0019941),2/201,0.596692974,0.646796964,0,0,1.000025508,0.516365751,NEDD4;RLIM
sensory perception of sound (GO:0007605),1/91,0.598298795,0.647507084,0,0,1.106116723,0.568173438,LRP2
toll-like receptor signaling pathway (GO:0002224),1/91,0.598298795,0.647507084,0,0,1.106116723,0.568173438,HSP90B1
positive regulation of apoptotic process (GO:0043065),3/310,0.598488062,0.647507084,0,0,0.971913847,0.498930711,BNIP3;CLU;DUSP6
generation of neurons (GO:0048699),2/202,0.59939979,0.648082007,0,0,0.994974619,0.509254351,MAP1B;ACSL4
protein ubiquitination (GO:0016567),5/525,0.601589251,0.649173321,0,0,0.955640365,0.485637679,NEDD4;ENC1;MKRN1;RLIM;CUL4B
regulation of lipid metabolic process (GO:0019216),1/92,0.602313979,0.649173321,0,0,1.093906094,0.554584585,ID2
negative regulation of mitotic cell cycle phase transition (GO:1901991),1/92,0.602313979,0.649173321,0,0,1.093906094,0.554584585,FHL1
positive regulation of cellular component biogenesis (GO:0044089),1/92,0.602313979,0.649173321,0,0,1.093906094,0.554584585,CLU
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/92,0.602313979,0.649173321,0,0,1.093906094,0.554584585,THBS1
regulation of epithelial cell proliferation (GO:0050678),1/93,0.606289228,0.65222023,0,0,1.081960913,0.541411221,LAMB1
visual perception (GO:0007601),1/93,0.606289228,0.65222023,0,0,1.081960913,0.541411221,COL18A1
positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.606289228,0.65222023,0,0,1.081960913,0.541411221,BRAF
protein polyubiquitination (GO:0000209),3/314,0.607181279,0.652356179,0,0,0.959216484,0.478579851,NEDD4;MKRN1;RLIM
cilium assembly (GO:0060271),3/314,0.607181279,0.652356179,0,0,0.959216484,0.478579851,TUBA1A;FLNA;PARVA
nucleosome organization (GO:0034728),1/94,0.610224939,0.655213167,0,0,1.070272619,0.528637226,ARID2
ciliary basal body-plasma membrane docking (GO:0097711),1/95,0.614121501,0.658567048,0,0,1.058833011,0.516247254,TUBA1A
sensory perception of light stimulus (GO:0050953),1/95,0.614121501,0.658567048,0,0,1.058833011,0.516247254,COL18A1
mitotic cell cycle phase transition (GO:0044772),2/209,0.617966827,0.661455235,0,0,0.960984821,0.462541695,TUBA1A;CUL4B
cellular transition metal ion homeostasis (GO:0046916),1/96,0.617979304,0.661455235,0,0,1.047634237,0.504226683,SLC40A1
regulation of vesicle-mediated transport (GO:0060627),1/96,0.617979304,0.661455235,0,0,1.047634237,0.504226683,INPP5F
regulation of transcription by RNA polymerase II (GO:0006357),21/2206,0.619190571,0.662335676,0,0,0.951163448,0.455932766,BEX1;CBX5;PEG3;PLA2G1B;DNMT3A;JMJD1C;ENO1;UTF1;GLI3;FOXP1;IMPACT;KLF6;NR6A1;EPCAM;ID2;DNMT3B;BBX;HDGF;LRRFIP1;SKIL;SSBP3
protein maturation (GO:0051604),1/97,0.621798731,0.663459635,0,0,1.036668771,0.49256158,F3
regulation of MAP kinase activity (GO:0043405),1/97,0.621798731,0.663459635,0,0,1.036668771,0.49256158,SPRY4
glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.621798731,0.663459635,0,0,1.036668771,0.49256158,GPC3
positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.621798731,0.663459635,0,0,1.036668771,0.49256158,GJA1
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.62558016,0.666392344,0,0,1.025929397,0.481238656,AP1M2
regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.62558016,0.666392344,0,0,1.025929397,0.481238656,BRAF
negative regulation of inflammatory response (GO:0050728),2/212,0.625720511,0.666392344,0,0,0.947111433,0.444054593,MYH9;ENPP3
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),1/99,0.629323969,0.669811395,0,0,1.015409194,0.470245238,POM121
positive regulation of protein modification process (GO:0031401),2/214,0.630821954,0.670986648,0,0,0.938080644,0.432203416,PLAUR;CALM1
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),1/100,0.63303053,0.672496274,0,0,1.00510152,0.459569229,AP1M2
cell-matrix adhesion (GO:0007160),1/100,0.63303053,0.672496274,0,0,1.00510152,0.459569229,ZYX
regulation of intracellular signal transduction (GO:1902531),4/437,0.635265916,0.674450543,0,0,0.917534198,0.416295911,CDC42;SPRED1;TMSB4X;ARHGAP29
cellular response to chemical stress (GO:0062197),1/101,0.636700212,0.675132023,0,0,0.995,0.449199077,PRDX6
positive regulation of cell cycle process (GO:0090068),1/101,0.636700212,0.675132023,0,0,0.995,0.449199077,CDC42
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.640333379,0.678140508,0,0,0.98509851,0.439123751,CLU
positive regulation of cell growth (GO:0030307),1/102,0.640333379,0.678140508,0,0,0.98509851,0.439123751,CDC42
protein targeting to ER (GO:0045047),1/103,0.643930394,0.681103284,0,0,0.975391167,0.429332705,EDEM1
antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.643930394,0.681103284,0,0,0.975391167,0.429332705,AP1M2
steroid metabolic process (GO:0008202),1/104,0.647491613,0.684020898,0,0,0.965872315,0.419815859,LRP2
mRNA transport (GO:0051028),1/104,0.647491613,0.684020898,0,0,0.965872315,0.419815859,POM121
activation of GTPase activity (GO:0090630),1/105,0.651017393,0.686893893,0,0,0.956536519,0.410563572,ARHGAP29
nucleotide-excision repair (GO:0006289),1/105,0.651017393,0.686893893,0,0,0.956536519,0.410563572,CUL4B
protein processing (GO:0016485),1/106,0.654508082,0.687596654,0,0,0.947378547,0.401566619,F3
chromosome organization (GO:0051276),1/106,0.654508082,0.687596654,0,0,0.947378547,0.401566619,CUL4B
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.654508082,0.687596654,0,0,0.947378547,0.401566619,NEDD4
RNA export from nucleus (GO:0006405),1/106,0.654508082,0.687596654,0,0,0.947378547,0.401566619,POM121
small GTPase mediated signal transduction (GO:0007264),1/106,0.654508082,0.687596654,0,0,0.947378547,0.401566619,G3BP2
peptidyl-lysine modification (GO:0018205),1/106,0.654508082,0.687596654,0,0,0.947378547,0.401566619,POM121
positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.654508082,0.687596654,0,0,0.947378547,0.401566619,CALM1
mRNA export from nucleus (GO:0006406),1/107,0.65796403,0.690801422,0,0,0.938393368,0.392816169,POM121
cilium organization (GO:0044782),2/228,0.665027815,0.697787806,0,0,0.879340551,0.358706236,FLNA;PARVA
response to tumor necrosis factor (GO:0034612),1/110,0.668126845,0.700608088,0,0,0.912427023,0.367961048,GBP2
Fc-epsilon receptor signaling pathway (GO:0038095),1/111,0.671447231,0.70295877,0,0,0.904086318,0.360115526,CALM1
regulation of Wnt signaling pathway (GO:0030111),1/111,0.671447231,0.70295877,0,0,0.904086318,0.360115526,GPC3
apoptotic process (GO:0006915),2/231,0.672018684,0.70295877,0,0,0.867687806,0.344879123,FEM1B;BNIP3
regulation of autophagy (GO:0010506),2/231,0.672018684,0.70295877,0,0,0.867687806,0.344879123,NEDD4;BNIP3
protein-containing complex subunit organization (GO:0043933),1/112,0.674734563,0.704934209,0,0,0.895895896,0.352477613,SLC2A1
Fc receptor signaling pathway (GO:0038093),1/112,0.674734563,0.704934209,0,0,0.895895896,0.352477613,CALM1
positive regulation of metabolic process (GO:0009893),1/113,0.677989166,0.707900453,0,0,0.887851732,0.345040465,GJA1
positive regulation of transcription by RNA polymerase II (GO:0045944),8/908,0.686821145,0.716138116,0,0,0.879627691,0.330459729,KLF6;BEX1;PEG3;EPCAM;PLA2G1B;UTF1;SSBP3;GLI3
ubiquitin-dependent protein catabolic process (GO:0006511),3/354,0.687133284,0.716138116,0,0,0.848159777,0.318252446,FEM1B;NEDD4;RLIM
cytosolic transport (GO:0016482),1/116,0.687559834,0.716138116,0,0,0.86455863,0.323869214,RHOBTB3
ion transport (GO:0006811),1/116,0.687559834,0.716138116,0,0,0.86455863,0.323869214,SLC1A3
positive regulation of cell projection organization (GO:0031346),1/117,0.690686736,0.718955528,0,0,0.857061999,0.317171997,STMN2
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.6937825,0.721296754,0,0,0.849693516,0.310645204,ADGRL2
regulation of protein binding (GO:0043393),1/118,0.6937825,0.721296754,0,0,0.849693516,0.310645204,ACTB
membrane organization (GO:0061024),2/242,0.696648444,0.723834724,0,0,0.827453469,0.29910323,LRP2;ACTB
cellular response to interferon-gamma (GO:0071346),1/121,0.702886029,0.729870684,0,0,0.828324916,0.292034664,GBP2
regulation of mRNA catabolic process (GO:0061013),1/122,0.705860293,0.732066914,0,0,0.821437516,0.286137857,YWHAZ
potassium ion transport (GO:0006813),1/122,0.705860293,0.732066914,0,0,0.821437516,0.286137857,SLC1A3
positive regulation of protein phosphorylation (GO:0001934),3/371,0.717233864,0.74298927,0,0,0.808271406,0.268631686,PLAUR;BRAF;CALM1
phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.717464012,0.74298927,0,0,0.794989899,0.263962476,INPP5F
positive regulation of signal transduction (GO:0009967),2/252,0.717699729,0.74298927,0,0,0.793949239,0.26335614,FLNA;F3
positive regulation of phosphorylation (GO:0042327),2/253,0.719736226,0.74464513,0,0,0.790745647,0.260052906,PLAUR;THBS1
positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.725866857,0.750532236,0,0,0.776238952,0.248698168,THBS1
G2/M transition of mitotic cell cycle (GO:0000086),1/130,0.728612175,0.752001906,0,0,0.770182445,0.243850302,TUBA1A
positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.728612175,0.752001906,0,0,0.770182445,0.243850302,GPC3
protein glycosylation (GO:0006486),1/130,0.728612175,0.752001906,0,0,0.770182445,0.243850302,GFPT2
cell cycle G2/M phase transition (GO:0044839),1/131,0.731330136,0.754350213,0,0,0.764219114,0.239116747,TUBA1A
regulation of cell adhesion (GO:0030155),1/133,0.736685071,0.758954874,0,0,0.752563514,0.229979489,TPM1
RNA metabolic process (GO:0016070),1/133,0.736685071,0.758954874,0,0,0.752563514,0.229979489,RBMS1
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.744518995,0.766562155,0,0,0.735727647,0.2170521,MYH9
regulation of protein phosphorylation (GO:0001932),2/266,0.745105609,0.766702873,0,0,0.751307491,0.221056688,IMPACT;PLAUR
"positive regulation of transcription, DNA-templated (GO:0045893)",10/1183,0.746098522,0.767261244,0,0,0.840245921,0.246106031,ACTA2;KLF6;BEX1;PEG3;EPCAM;PLA2G1B;ID2;UTF1;SSBP3;GLI3
protein-containing complex assembly (GO:0065003),2/267,0.746973638,0.767342753,0,0,0.748434058,0.218337214,AFDN;SLC2A1
regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.74707842,0.767342753,0,0,0.730280749,0.212938999,MYH9
positive regulation of nucleic acid-templated transcription (GO:1903508),4/511,0.751687971,0.770663955,0,0,0.780620037,0.222815479,ACTA2;KLF6;ID2;GLI3
regulation of cellular component organization (GO:0051128),1/139,0.752120984,0.770663955,0,0,0.719623774,0.20499065,NEDD4
positive regulation of response to external stimulus (GO:0032103),1/139,0.752120984,0.770663955,0,0,0.719623774,0.20499065,THBS1
potassium ion transmembrane transport (GO:0071805),1/139,0.752120984,0.770663955,0,0,0.719623774,0.20499065,SLC1A3
enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.754604627,0.772280051,0,0,0.71441029,0.201150318,PTPRF
transcription initiation from RNA polymerase II promoter (GO:0006367),1/140,0.754604627,0.772280051,0,0,0.71441029,0.201150318,NR6A1
positive regulation of cellular catabolic process (GO:0031331),1/141,0.757063508,0.774331463,0,0,0.709271284,0.197395968,BNIP3
chromatin organization (GO:0006325),1/142,0.759497874,0.775192406,0,0,0.704205172,0.193725263,NUDT5
protein localization to organelle (GO:0033365),1/142,0.759497874,0.775192406,0,0,0.704205172,0.193725263,GBP2
inorganic cation transmembrane transport (GO:0098662),2/274,0.759724951,0.775192406,0,0,0.728911615,0.20030405,SLC40A1;SLC1A3
positive regulation of MAPK cascade (GO:0043410),2/274,0.759724951,0.775192406,0,0,0.728911615,0.20030405,GLIPR2;BRAF
protein-DNA complex assembly (GO:0065004),1/143,0.761907967,0.776954623,0,0,0.699210414,0.190135945,CUL4B
positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.771310392,0.786072314,0,0,0.679915594,0.176549876,PLA2G1B
brain development (GO:0007420),1/150,0.778118915,0.791590824,0,0,0.666124331,0.167114554,ADGRL2
regulation of cytokine production (GO:0001817),1/150,0.778118915,0.791590824,0,0,0.666124331,0.167114554,FOXP1
response to cytokine (GO:0034097),1/150,0.778118915,0.791590824,0,0,0.666124331,0.167114554,PTPN14
proteolysis (GO:0006508),2/287,0.781940921,0.795004373,0,0,0.695199929,0.17100256,CAPN2;F3
positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.784725721,0.797359945,0,0,0.652877459,0.158271221,GPC3
cellular response to interleukin-1 (GO:0071347),1/155,0.789021138,0.801246734,0,0,0.64433294,0.15268253,GBP2
regulation of cell differentiation (GO:0045595),1/156,0.791136758,0.802438712,0,0,0.640143369,0.149975627,ID2
peptidyl-serine phosphorylation (GO:0018105),1/156,0.791136758,0.802438712,0,0,0.640143369,0.149975627,RPS6KA6
skeletal system development (GO:0001501),1/158,0.79530488,0.806186505,0,0,0.631924339,0.144729468,GJA1
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.809252138,0.819836887,0,0,0.604736388,0.127989278,ADGRL2
cellular protein-containing complex assembly (GO:0034622),1/168,0.814936155,0.825104698,0,0,0.593782133,0.121514845,CLU
peptidyl-serine modification (GO:0018209),1/169,0.816793122,0.826493753,0,0,0.590217653,0.119442012,RPS6KA6
cellular macromolecule biosynthetic process (GO:0034645),2/314,0.822412369,0.831685862,0,0,0.634159833,0.12398671,PCLAF;RBMS1
cation transport (GO:0006812),1/174,0.825803506,0.834619914,0,0,0.573013371,0.109673854,LRP2
mitochondrion organization (GO:0007005),1/175,0.827551956,0.835891247,0,0,0.569691165,0.107833073,BNIP3
transcription by RNA polymerase II (GO:0006366),2/320,0.830442451,0.838313943,0,0,0.622003001,0.115566072,NR6A1;NOCT
ribosome biogenesis (GO:0042254),1/192,0.854740341,0.862331285,0,0,0.518536147,0.081388164,CUL4B
regulation of signal transduction (GO:0009966),1/198,0.863280354,0.870331082,0,0,0.502589345,0.073888565,CLU
"regulation of transcription, DNA-templated (GO:0006355)",18/2244,0.863691233,0.870331082,0,0,0.785170735,0.115058875,CBX5;PEG3;SFMBT2;JMJD1C;ENO1;UTF1;GLI3;FOXP1;ACTA2;DNMT3L;KLF6;NR6A1;ID2;RLIM;BBX;HDGF;LRRFIP1;CRYAB
endomembrane system organization (GO:0010256),1/199,0.864654299,0.870786599,0,0,0.500025508,0.072716462,CDC42
ncRNA processing (GO:0034470),1/201,0.867361109,0.872996651,0,0,0.494974747,0.070434849,LIN28A
gene expression (GO:0010467),2/356,0.87212189,0.877270189,0,0,0.557716023,0.076310099,POM121;RBMS1
translation (GO:0006412),1/214,0.883688961,0.888381115,0,0,0.464456774,0.057430142,PPA1
"transcription, DNA-templated (GO:0006351)",1/221,0.891635711,0.89584154,0,0,0.449517906,0.051558637,NOCT
inflammatory response (GO:0006954),1/230,0.901064061,0.904780884,0,0,0.431652772,0.044969121,THBS1
organelle assembly (GO:0070925),2/425,0.926904512,0.930179793,0,0,0.465085022,0.035302151,FLNA;PARVA
regulation of nucleic acid-templated transcription (GO:1903506),2/430,0.929865897,0.932602407,0,0,0.459533185,0.033414909,JMJD1C;ACTN4
protein deubiquitination (GO:0016579),1/267,0.931978855,0.934171747,0,0,0.370908331,0.026128694,ACTB
protein modification by small protein removal (GO:0070646),1/276,0.937910277,0.939564439,0,0,0.358604224,0.022986885,ACTB
DNA repair (GO:0006281),1/298,0.950331091,0.951447814,0,0,0.331666837,0.016896713,CUL4B
innate immune response (GO:0045087),1/302,0.952307677,0.952866871,0,0,0.327192188,0.015988935,PLA2G1B
regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.991221438,0.991221438,0,0,0.209093072,0.001843641,JMJD1C
